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MYOGENIN MODULATES EXERCISE ENDURANCE BY ALTERING SKELETAL
MUSCLE METABOLISM

PROJECT I – ABSTRACT

The function of myogenic regulatory factors (MRFs) during adult life is not well
understood. The requirement of one of these MRFs, myogenin (Myog), during embryonic
muscle development suggests an equally important role in adult muscle. In this study, we have
determined the function of myogenin during adult life using a conditional allele of Myog. In
contrast to embryonic development, myogenin is not required for adult viability, and Myogdeleted mice exhibited no remarkable phenotypic changes during sedentary life. Remarkably,
sedentary Myog-deleted mice demonstrated enhanced exercise endurance during involuntary
treadmill running. Altered blood glucose and lactate levels in sedentary Myog-deleted mice
after exhaustion suggest an enhanced glycolytic metabolism and an ability to excessively
deplete muscle and liver glycogen stores. Traditional changes associated with enhanced
exercise endurance, such as fiber type switching, and increased oxidative potential, were not
detected in sedentary Myog-deleted mice. After long-term voluntary exercise, trained Myogdeleted mice demonstrated an enhanced adaptive response to exercise. Trained Myog-deleted
mice exhibited superior exercise endurance associated with an increased proportion of slowtwitch fibers and increased oxidative capacity. In a parallel experiment, dystrophin-deficient
young adult mice showed attenuated muscle fatigue following the deletion of Myog. These
results demonstrate a novel and unexpected role for myogenin in modulating skeletal muscle
metabolism.

iv

MYOGENIN TARGET GENE ACTIVATION IN ADULT MUSCLE STEM CELLS

PROJECT II - ABSTRACT

Skeletal muscle development is a complex biological process that is regulated by the
expression of myogenic regulatory factors (MRFs). Myogenin (Myog) is one of these MRFs,
which is involved in the differentiation and fusion of embryonic myoblasts and adult satellite
(stem) cells into myofibers. Knockout of Myog during embryonic development results in
perinatal death due to the loss of properly differentiated and fused muscle fibers (Hasty et al.,
1993; Nabeshima et al., 1993). MyoD is a related MRF with broad functions during
myogenesis, including involvement in myoblast specification and differentiation (Berkes and
Tapscott, 2005). My hypothesis is that genes can be identified whose expression is strictly
dependent on Myog versus MyoD. The aim of this project is to distinguish the differences in
transcriptional activation by myogenin compared to MyoD. Regardless of the outcome, our
experiments will provide a better understanding of the mechanisms underlying myoblast
differentiation and muscle gene expression.
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PROJECT I

Myogenin modulates exercise endurance by altering skeletal muscle metabolism

1

Chapter 1 - Introduction

The regulation of gene expression in skeletal muscle is critical to orchestrating muscle
exercise adaptation and regeneration upon injury. The ability of skeletal muscle to enhance
exercise endurance and to resist fatigue are key adaptive mechanisms (Holloszy and Coyle,
1984). Skeletal muscle wasting and degeneration are commonly associated with the muscular
dystrophies. Progressive muscle weakness and muscle degeneration occur when essential
proteins that transmit force from within the skeletal muscle fiber to the extracellular matrix are
dysfunctional (Wallace and McNally, 2009).

Section 1.1 – Skeletal muscle fiber type and metabolism

Skeletal muscle is composed of various types of myofibers, each exhibiting unique
characteristics that allow contraction under low- and high-intensity loads and that perform work
under aerobic and anaerobic conditions (Schiaffino et al., 2007). Although there are no widely
accepted rules about defining muscle fiber types, classifications are often made using fiber
color, expression of myosin isoforms, or metabolic profile (Schiaffino et al., 2007). In addition,
different fiber types vary in their myoglobin content, mitochondrial density, vascularization, and
resistance to fatigue. Muscle fibers are broadly separated into the following categories: Type-I
slow-twitch oxidative, Type-IIa fast-twitch oxidative/glycolytic, and Type IIb fast-twitch
glycolytic. Type IIx, and not Type-IIb is the major fast-twitch glycolytic muscle fiber in
humans. Myosin isoforms are readily distinguished from one another by their ATP hydrolysis
activity. Myoglobin content helps maintain oxygen consumption in exercising muscle (Cole,
1982). Mitochondrial content ultimately determines the oxidative capacity of skeletal muscle
(Gnaiger, 2009). Increasing oxidative capacity has a direct relationship with the degree of
2

vascularization within the muscle. Type-I fibers represent a population of muscle fibers with
high content of myoglobin and mitochondria, reliance on oxidative metabolism to perform
work, and expression of myosin Type-I as the primary myosin isoform (Schiaffino et al., 2007)
(Figure 1). Type-I fibers efficiently use oxidative metabolism to derive 36 molecules of ATP
per glucose molecule via the TCA cycle from fatty acid oxidation. The muscles in marathon
runners have an enriched proportion of Type-I muscle fibers and are fatigue resistant (Booth and
Thomason, 1991). Type-IIa fibers represent a population of muscle fibers with a high content of
myoglobin and mitochondria, reliance on both oxidative and glycolytic metabolism to perform
work, and expression of myosin Type-IIa as the primary myosin isoform (Schiaffino et al.,
2007). Like Type-I fibers, Type-IIa fibers efficiently produce ATP over long periods. Type-IIb
and IIx fibers represent a population of muscle fibers with a low content of myoglobin and
mitochondria, reliance on glycolysis to produce ATP for muscle contraction, and expression of
myosin Type-IIb as the primary myosin isoform (Schiaffino et al., 2007) (Figure 1). The
reliance of IIb and IIx fibers on glycolysis indicates they have a lower requirement for oxygen,
however, due to incomplete oxidation, they yield of ATP is only 2. Type-IIb and IIx fibers do
not require oxygen and make two molecules of ATP per glucose molecule. Although glycolytic
metabolism is less efficient at ATP production than oxidative metabolism, it can generate ATP
much faster overall. Sprinters have an enriched proportion of Type-IIx muscle fibers and are
less fatigue resistant (Booth and Thomason, 1991).
The unique ability of Type-I and Type-II fibers to make ATP under various conditions
also makes their substrates and metabolites unique. In general, Type-I and Type-IIa muscle
fibers efficiently metabolize glucose and fatty acids to produce ATP. Type-IIb muscle fibers
primarily metabolize glucose due to a low abundance of mitochondria (Hamilton and Booth,
2000; Schiaffino et al., 2007). Lactate is a major by-product of exercise metabolism,
accumulating when only glycolysis can sustain the energy demand (i.e. high-intensity exercise)
3

Figure 1 – Metabolism, fiber-type, and exercise performance
Sprinters and marathoners have very different physical abilities that are primarily determined by
muscle metabolism and fiber-type. Sprinters have enrichment in fast-twitch muscle fibers,
which primarily derive ATP by glycolytic metabolism. Fast-twitch fibers using glycolytic
metabolism allow sprinters to perform high-intensity work, but for only short periods of time
prior to exhaustion. Sprinters primarily use glucose as an energy source. The onset of
exhaustion is typically associated with the excess accumulation of lactate, which is produced
when oxygen availability is limited (anaerobic conditions). Marathoners have enrichment in
slow-twitch muscle fibers, which primarily utilize oxidative metabolism to perform work.
Slow-twitch fibers using oxidative metabolism allow marathoners to perform low-intensity
work, but for very long periods of time prior to exhaustion. Marathoners use fatty acids as an
energy source, while efficiently conserving glucose. The onset of exhaustion in marathoners is
typically associated with the depletion of liver and muscle glycogen stores (glucose). In
marathoners, lactate is not created in excess because oxygen is plentiful (aerobic conditions).
Myosin ATPase fiber-typing shown. Dark fibers represent Type-I slow fibers; Light fibers
represent Type-II fibers.
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(Gladden, 2008). The lactate shuttle (Cori Cycle) is a metabolic pathway that involves skeletal
muscle and liver (Figure 2). As glycolytic pathways are stressed in skeletal muscle (i.e. highintensity exercise), pyruvate increases in the absence of oxygen, thus favoring lactate formation.
Lactate is transported from working skeletal muscle into the bloodstream and is taken up by
non-working skeletal muscle and the liver. Non-working skeletal muscle and liver convert
lactate back into pyruvate, which is either metabolized via the TCA cycle or the liver converts
the pyruvate into glucose (or glycogen) through gluconeogenesis and releases the glucose into
the bloodstream. The working skeletal muscle will use the circulating blood glucose for energy
production (Gladden, 2000).
Blood lactate concentration is arguably the most well-studied and often-measured
metabolite associated with exercise performance. The production of lactate is not only an
indication of glycolytic activity, but has been long argued to be directly associated with muscle
fatigue and exhaustion (Asmussen, 1956; Fitts, 1994). While the onset of muscle fatigue is
controversial, fatigue is generally thought to be due to the production of excess hydrogen ion
(associated with lactic acid production) and the resultant drop in intramuscular pH levels (Fitts,
2004). Lactic acid ultimately breaks down within the skeletal muscle to form hydrogen and
lactate ions. The clearance of these metabolites is essential to normal muscle function.
Traditionally, the increased acidic environment is believed to be detrimental to sarcomeric
contractile protein function (Fitts, 2004). Recently, however, other studies have shown that
lactic acid production does not cause muscle fatigue and may actually enhance exercise
performance (Allen and Westerblad, 2004; Allen et al., 2008; Pedersen et al., 2004). Thus, the
ability to increase lactic acid production during exercise may confer enhanced high-intensity
exercise endurance.

6

Figure 2 – The lactate shuttle (Cori Cycle)
As skeletal muscle performs work under anaerobic conditions, intramuscular lactate
concentration increases. Lactate diffuses into the bloodstream and is taken up by the liver and
non-working skeletal muscle. In the liver, lactate is converted back into pyruvate and is
ultimately converted back into glucose through gluconeogenesis. The glucose is released back
into the bloodstream and taken up by the working skeletal muscle, thus completing the cycle
(Bender DA, 2009). Used with permission from McGraw Hill Publishers.
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Section 1.2 – The MRFs orchestrate skeletal muscle development

Normal muscle development and function is dependent on the cooperation of all skeletal
muscle components, and the proper expression of these components requires the activity of the
Myogenic Regulatory Factors (MRFs). To better understand the mechanisms underlying
muscle adaptation to exercise and muscular dystrophies during adult life, the precise function of
MRFs in adult skeletal muscle must be determined. MRFs generally help coordinate the
development, maintenance, and repair of skeletal muscle fibers (Charge and Rudnicki, 2004)
(Figure 3). Myogenin is a basic-Helix-Loop-Helix (bHLH) skeletal muscle-specific
transcription factor and a member of the MRF family. To efficiently activate the expression of
muscle-expressed genes, myogenin heterodimerizes with ubiquitously expressed E-proteins in
order to bind to the consensus E-box motif (Berkes and Tapscott, 2005; Olson and Klein, 1994).
The Mef2 class of proteins also cooperate with MRFs to provide a synergistic effect on muscle
gene activation (Black and Olson, 1998). When Myog expression is knocked out during
embryonic myogenesis, mice die at birth due to the absence of skeletal muscle fibers, and thus
leading to asphyxiation caused by poor diaphragm development (Hasty et al., 1993; Meadows et
al., 2008; Nabeshima et al., 1993) (Figure 4). Importantly, Myog is the only single MRF
knockout that exhibits gross skeletal muscle defects and no other factors compensate for its loss
(Venuti et al., 1995). To better understand the role of MRFs during postnatal life, mice
harboring Myogflox conditional alleles were generated (Knapp et al., 2006) (Figure 5). Upon
deletion of Myog immediately after birth, Myog-deleted mice reach adulthood with normal
skeletal muscle (consistent myofiber area and non-centrally located nuclei) but proportionally
smaller body size (Knapp et al., 2006; Meadows et al., 2008) (Figure 4).
Depending on environmental pressures (i.e. exercise training), mature skeletal muscle
can undergo phenotypic changes that allow adaptation. Environmental cues lead to changes in
9

Figure 3 – MRFs coordinate skeletal muscle development
During embryonic myogenesis, myogenic precursor cells (MPCs) are specified to the myogenic
fate with the expression of Pax3 or Pax7. Pax3-expressing MPCs go on to upregulate the
myogenic program; in turn Myf5, MyoD, and Mrf4 commit the MPCs to the myogenic fate and
coordinate their proliferation as myoblasts. Myogenin and MRF4 are next upregulated, causing
the cells to differentiate and fuse with one another to form multi-nucleated myofibers. During
postnatal and adult life, satellite (muscle stem) cells arise from Pax7-expressing MPCs,
specifying them to the myogenic fate. Satellite cells reside alongside each myofiber in a
quiescent state. Inductive cues, such as muscle growth or injury/repair, will initiate the
myogenic program to contribute additional myofibers to the skeletal muscle. Modified from
(Charge and Rudnicki, 2004).
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Figure 4 – The requirement for myogenin throughout life
Myogenin is required during embryonic and fetal myogenesis, and must be properly expressed
until birth. The absence of myogenin after birth leads to proportionally reduced myofiber size
and body mass (Meadows et al., 2008). The function of myogenin during adult life is addressed
in this study.
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Figure 5 – Myogflox conditional allele
A conditional allele of Myog incorporates LoxP sites upstream of exon I and flanking a
neomycin cassette inserted within intron I. A tamoxifen-inducible Cre-recombinase is utilized
to conditionally mediate a site-specific recombination event at the LoxP sites. Following
tamoxifen treatment, exon I of the Myogflox allele is recombined, giving a Myog-deleted locus.
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nerve-dependent electrical activity and vascularization that ultimately determines muscle fiber
characteristics. While dramatic changes in fiber type have been experimentally induced (Mayne
et al., 1993; Windisch et al., 1998), less dramatic changes have been observed in mammals that
have undergone exercise training (Fitts, 1996). Exercise training induces changes in
metabolism that may be associated with changes in fiber type proportion (i.e. Type IIb/IIx to
Type IIa) (Abdelmalki et al., 1996; Kraemer et al., 1995; Schluter and Fitts, 1994; Wang et al.,
1993). Although the plasticity of muscle under experimentation and exercise training is welldescribed, the intramuscular pathways that link the changes in environmental demand to the
necessary changes in contractile and metabolic proteins are poorly understood.

Section 1.3 – The MRFs and muscular dystrophy

The MRFs play a role in coordinating changes in gene expression with innervationdependent electrical activity. For example, myogenin and MyoD expression were found to
selectively accumulate in slow- and fast-twitch skeletal muscle fibers, respectively. This
relationship is controlled by muscle innervation, as cross-reinnervation of a slow-twitch muscle
by a nerve from a fast-twitch muscle shifts gene expression patterns towards a fast-twitch
profile (Hughes et al., 1993). Yet, when myogenin was over-expressed in fast-twitch muscles,
muscle enzyme activity shifted from glycolytic towards oxidative metabolism independent of
changes in myosin isoform expression (Hughes et al., 1999). These results demonstrate that
myogenin expression mediates the effects of muscle innervation on slow-twitch muscle fibers
and activates properties associated with oxidative metabolism.
The role of MRFs in maintaining normal muscle gene expression in the presence of a
muscular dystrophy is not well understood. Muscle-expressed proteins normally organize to
form skeletal muscle’s basic contractile apparatus, the sarcomere (Gordon et al., 2000).
16

Transmission of force from the sarcomere to the surrounding connective tissue is essential to
survival. Muscle proteins involved in the generation and transmission of force are regularly
turned over or damaged throughout adult life and require MRF activity for regeneration (Charge
and Rudnicki, 2004). Absent or defective sarcomere components or neighboring dystrophin
complex components lead to a multitude of muscular dystrophies, some of which are well
understood but have no available cures (Blake et al., 2002; Kontrogianni-Konstantopoulos et al.,
2009). Given that the development of these muscle components is dependent on MRF activity,
understanding the precise requirement of each MRF (i.e. myogenin) in maintaining normal
muscle gene expression in muscular dystrophies is essential to understanding muscle
regeneration and developing therapies.
Duchenne Muscular Dystrophy, caused by dystrophin deficiency, is the most prevalent
muscular dystrophy in humans, affecting 1 in 3500 newborn males (Blake et al., 2002).
Dystrophin is the largest gene in the human genome at 2.4MB and is the major constituent of
the dystrophin complex. The dystrophin complex serves to connect the cytoskeleton of the
muscle fiber to the extracellular matrix and to functionally transmit forces produced at the
sarcomere to the tendons and bones (Figure 6). Mice lacking dystrophin are not severely
affected due to compensation by a homolog of dystrophin, utrophin (Grady et al., 1997). The
severity of the dystrophin-deficiency in mice is highly dependent on background strain,
although age and muscle use also plays a significant factor (Chamberlain et al., 2007;
Heydemann et al., 2005). Exercise training mice with muscular dystrophy proves to be
beneficial or deleterious, depending on the severity of the dystrophy, animal age, exercise
intensity, exercise duration, and exercise type (aerobic vs resistive strength) (Carter et al., 2002).
This study aims to identify functions for myogenin during adult life and to determine
whether exercise endurance and muscular dystrophy are affected by the loss of myogenin. We
hypothesize that myogenin is required for muscle function and maintenance of normal skeletal
17

muscle metabolism during adult life. If the hypothesis is correct, the lack of myogenin should
adversely affect exercise endurance and dystrophic skeletal muscle by disrupting the normal
expression of critical skeletal muscle enzymes and components.

18

Figure 6 – Dystrophin and the dystrophin-associated complex
Dystrophin is a protein that helps hold together the muscle cell wall (sarcolemma). Dystrophin
anchors actin filaments within the myofiber to the sarcolemmal membrane, providing both
structural support and a means for force transduction. Other proteins, such as laminin,
dystroglycan, and sarcoglycan are found in the dystrophin-associated complex and play similar
roles in anchoring myofibers alongside the basal lamina. Robbins & Cotran – Pathologic Basis
of Disease, 2010. Used with permission from Elsevier Publishing.
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Hypothesis

Myogenin is required for muscle function and maintaining normal skeletal muscle
metabolism during adult life. The lack of myogenin will adversely affect exercise endurance and
dystrophic skeletal muscle by disrupting the normal expression of critical skeletal muscle
metabolic enzymes and structural components.

Specific Aims

1.) Determine whether myogenin is required for adult muscle function. We will
conditionally delete Myog and characterize Myog-deleted mice. Functional studies such
as involuntary and voluntary exercise will be used to test muscle function. Blood
metabolite levels, fiber type, oxidative capacity, and gene expression will be analyzed
for changes associated with exercise.

2.) Determine whether endurance exercise is dependent on myogenin. Myog-deleted
mice will be stressed during adult life using voluntary and involuntary exercise. Muscle
function and exercise capacity will be assayed by measuring average distance, average
speed, and maximum speed during exercise.

3.) Determine whether muscle maintenance and regeneration occur normally in
dystrophic mice lacking myogenin. Myog will first be deleted from dystrophic young
adult mice. Exercise performance will then be measured using involuntary treadmill
running. Myofiber pathology will be analyzed with H&E staining and dystrophin

21

antibody staining. In addition, myofiber ultrastructure will be analyzed using
Transmission Electron Microscopy (TEM).

22

Chapter 2 - Results

Section 2.1 - Myogenin is not essential for viability or maintaining normal weight during adult
life

To determine whether myogenin is required during adult life, Myogflox/flox; Cre+ mice
were injected with tamoxifen between 6 and 8 weeks of age, the age at which mice nearly
complete postnatal growth and reach adulthood. Control mice not expressing the tamoxifeninducible Cre were also injected with tamoxifen. Average deletion of Myog obtained was 96%
as determined by qPCR (Figure 7A). Skeletal muscle-specific reduction of Myog transcripts
was determined by RT-qPCR to be less than 1% in gastrocnemius muscle (Figure 7B). By one
year of age, Myog-deleted mice displayed no observable changes in behavior or mobility and
weighed the same as control mice (Figure 7C). These results indicate that sedentary mice do not
require myogenin for survival during adult life.

Section 2.2 - Lack of myogenin during adult life confers enhanced exercise endurance

A physiological function for myogenin during adult life was discovered when mice underwent
involuntary exercise regimes using a rodent treadmill (Figures 8, 9). Using a low-intensity
exercise protocol, Myog-deleted mice ran 2.4-fold farther than control mice (Figure 10). On
average, wild-type mice ran 4,000 meters until exhaustion while Myog-deleted mice ran 10,000
meters until exhaustion. Next, we subjected mice to a high-intensity exercise protocol where we
observed that Myog-deleted mice consistently ran 1.6-fold farther than control mice during 12
days of treadmill running (Figure 11). On average, wild-type mice ran 382 meters daily until
exhaustion while Myog-deleted mice ran 599 meters daily until exhaustion. Mice used in these
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Figure 7 – Efficient deletion and viability of adult Myog-deleted mice
qPCR reveals efficient 96% deletion of Myog genomic DNA in adult mice following tamoxifen
treatment (n=10 wild-type control, n=12 Myog-deleted) (A). At one year of age, hind limb
muscle of Myog-deleted mice exhibited dramatically reduced expression of Myog less than 1%
of wild-type control mice, as shown by RT-qPCR (n=3 per group) (B). One-year-old Myogdeleted mice weigh the same as wild-type control mice (n=11 per group) (C). Blue bars indicate
wild-type control values; red bars indicate Myog-deleted values. Error bars represent one
standard deviation. *p<0.05
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Figure 8 – Columbus Instruments Exer 3/6 Treadmill
To facilitate exercise-induced muscle stress and injury, a Columbus Instruments Exer 3/6
Treadmill was used with low- and high-intensity protocols (see Methods & Figure 9). The
treadmill allows for user-defined features such as incline and speed control. An electrical
stimulus grid at the rear of the belt provides encouragement to run until exhaustion. Six running
lanes accommodate up to 6 mice per running experiment.
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Figure 9 – Low- and high-intensity running regimes
Low-intensity exercise running (green line) consists of a 30 minute warmup period at 10 M/min
followed by running at 20 M/min until exhaustion. High-intensity running (red line) consists of
a 10 minute warmup period at 10 M/min followed by running at an additional 2 M/min every 2
minutes until exhaustion. Exhaustion is defined when mice prefer to stand on the electrical
stimulus grid for 10 seconds rather than run.
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Figure 10 – Myog-deleted mice run significantly farther than wild-type mice during lowintensity exercise. During low-intensity exercise, Myog-deleted mice ran 2.4-fold farther than
wild-type mice (Myog-deleted n=4, wild-type n=6). Blue bar indicates wild-type control values;
red bar indicates Myog-deleted values. Error bars represent one standard deviation. *p<0.05
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Figure 11 – Myog-deleted mice consistently run farther than wild-type mice during highintensity exercise. During 12 consecutive days of high-intensity exercise, Myog-deleted mice
ran 1.6-fold farther than wild-type mice on average (Myog-deleted 599 meters, wild-type 382
meters) (wild-type n=7, Myog-deleted n=8). Blue line and bar indicate wild-type control values;
red line and bar indicate Myog-deleted values. Error bars represent one standard deviation.
*p<0.01
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experiments were approximately six-months of age and all female. Myog-deleted mice
exhibited a slight trend towards a 15% body weight reduction by 1.5 years of age after repeated
treadmill experiments (data not shown). The enhanced exercise capacity during low- and highintensity running suggests that myogenin may modulate normal skeletal muscle metabolic
activity.
To determine how quickly the phenotype manifests after the deletion of Myog, and
whether the enhanced exercise capacity is also observed in males, a large cohort of young adult
mice were subjected to high-intensity treadmill running within 10 days of tamoxifen injection.
On average, Myog-deleted mice ran 1.4-fold farther than wild-type mice (Myog-deleted 547
meters, wild-type 402 meters) (Figure 12A). Myog-deleted males exhibited a greater tendency
for enhanced exercise capacity than females, running 1.6-fold farther than wild-type males
(Myog-deleted 540 meters, wild-type 336 meters) (Figure 12B). Myog-deleted females showed
a strong trend (not significant) towards running nearly 20% farther than wild-type females
(Myog-deleted 555 meters, wild-type 468 meters) (Figure 12C). These results demonstrate that
the enhanced exercise capacity of Myog-deleted mice is observed within a short period of time
after the deletion of Myog.

Section 2.3 - Lack of myogenin alters blood metabolite concentrations during exhaustive
exercise

To better understand the metabolic requirements of Myog-deleted mice during exercise
and fatigue, blood glucose and blood lactate levels were measured during and after low- and
high-intensity treadmill exercise. Blood lactate and glucose baseline levels were measured in
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Figure 12 – Myog-deleted mice exhibit enhanced exercise capacity shortly after the deletion of
Myog. Young-adult mice were subjected to high-intensity running 10 days after tamoxifen
treatment. Myog-deleted mice exhibited a 1.4-fold increase in exercise endurance relative to
wild-type control mice (Myog-deleted 547 meters, wild-type 402 meters, n=24 mice/group)
(12A). Myog-deleted males ran 1.6-fold farther than wild-type males (Myog-deleted 540
meters, wild-type 336 meters, n=12 mice/group) (12B). Myog-deleted females showed a strong
trend (p=0.06) towards running nearly 20% farther than wild-type females (Myog-deleted 555
meters, wild-type 468 meters, n=12 mice/group) (12C). Blue bars indicate wild-type control
values; red bars indicate Myog-deleted values. Error bars represent one standard deviation.
*p<1x10-4
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Myog-deleted mice before all low- and high-intensity treadmill runs and determined as normal
(3.2 mM Lactate, 149 mg/dL Glucose) (Figures 13, 14, 16, 17). At low-intensity exercise
exhaustion, blood lactate was not significantly different from baseline levels or control mice
(4.2 mM), while blood glucose levels were reduced 2.4-fold in Myog-deleted mice (Myogdeleted 33 mg/dL, Wild-type 80 mg/dL) (Figures 13, 14). The 50% reduction of blood glucose
levels in wild-type mice at exhaustion is defined herein as a hypoglycemic state. Blood ketone
levels were also measured after low-intensity exercise and determined as normal in Myogdeleted mice. After low-intensity exercise exhaustion, Myog-deleted mice showed a trend
towards a 1.5-fold increase in blood ketone levels (Myog-deleted 2.9 mM, wild-type 1.9 mM)
(Figure 15).
Blood lactate and glucose were next measured during and after high-intensity exercise
exhaustion. After wild-type mice reached exhaustion under high-intensity exercise, their blood
lactate was elevated to 8.6 mM while blood lactate was only mildly elevated to 4.5 mM in
Myog-deleted mice at wild-type exhaustion (Figure 17); blood glucose remained unchanged in
wild-type mice while blood glucose showed a trend towards reduction in Myog-deleted mice at
wild-type exhaustion (Figure 16). After Myog-deleted mice reached exhaustion, blood lactate
was significantly elevated to 12.9 mM while blood glucose was significantly reduced to 105
mg/dL (Figures 16, 17). The excessive production of lactate and increased utilization of glucose
as source of fuel suggests that Myog-deleted mice exhibit increased glycolytic flux during highintensity exercise.

Section 2.4 - Myogenin is not necessary to maintain normal muscle fiber type, aerobic potential,
or expression of genes involved in fatty-acid metabolism
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Figure 13 – Myog-deleted mice have normal blood lactate levels after low-intensity running.
Blood lactate levels in Myog-deleted mice are similar to wild-type mice before and after lowintensity exercise (Myog-deleted 3.2 mM, wild-type 4.2 mM). Blue bars indicate wild-type
control values; red bars indicate Myog-deleted values. Error bars represent one standard
deviation.
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Figure 14 – Myog-deleted mice have reduced blood glucose levels after low-intensity running.
Blood glucose levels in Myog-deleted mice are similar to wild-type prior to low-intensity
exercise (149 mg/dL). After low-intensity exercise exhaustion, blood glucose levels were
reduced 78% in Myog-deleted mice compared to 46% for wild-type controls (Myog-deleted 33
mg/dL, wild-type 80 mg/dL). Blue bars indicate wild-type control values; red bars indicate
Myog-deleted values. Error bars represent one standard deviation. *p<0.05
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Figure 15 – Myog-deleted mice exhibit a trend towards increased blood ketone levels after lowintensity running. Myog-deleted mice have normal blood ketone levels prior to exercise (Myogdeleted 0.2 mM, wild-type 0.15 mM). After exhaustion, Myog-deleted mice exhibit a trend
(p=0.09) towards a 1.5-fold increase in blood ketone levels relative to wild-type control mice
(Myog-deleted 2.9 mM, wild-type 1.9 mM). Blue bars indicate wild-type control values; red
bars indicate Myog-deleted values. Error bars represent one standard deviation.
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Figure 16 - Myog-deleted mice have lower blood glucose levels after high-intensity
exercise compared to wild-type mice. Prior to exercise, Myog-deleted mice have normal
blood glucose levels compared to wild-type control mice (149 mg/dL). As wild-type
mice reach exhaustion, their blood glucose levels are elevated, but not significantly
different than pre-exercise values (162 mg/dL). At the point of wild-type exhaustion,
Myog-deleted mice exhibit a trend towards a 29% reduction in blood glucose levels. At
exhaustion, Myog-deleted mice exhibit a 33% reduction in blood glucose relative to wildtype exhaustion (Myog-deleted n=6, wild-type n=6). Blue bars indicate wild-type control
values; red bars indicate Myog-deleted values. Error bars represent one standard
deviation. *p<0.05
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Figure 17 – Myog-deleted mice have higher blood lactate levels after high-intensity
exercise compared to wild-type mice. Prior to exercise, Myog-deleted mice exhibited
normal levels of blood lactate (Myog-deleted 3.1 mM, wild-type 3.2 mM). Exhausted
wild-type mice exhibited elevated blood lactate levels (8.6 mM), 2.7-fold higher than preexercise levels. Also at wild-type exhaustion, Myog-deleted mice had blood lactate levels
similar to pre-exercise levels. Exhausted Myog-deleted mice exhibited a dramatic 4.2fold increase in blood lactate relative to pre-exercise levels, and 1.5-fold higher than
exhausted wild-type mice (12.9 mM) (Myog-deleted n=6, wild-type n=6). Blue bars
indicate wild-type control values; red bars indicate Myog-deleted values. Error bars
represent one standard deviation. *p<0.05
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Myosin-ATPase and Succinate Dehydrogenase (SDH) assays were performed on
histological sections of muscle tissue from Myog-deleted mice. No difference in the proportion
of Type-I and Type-II myofibers was detected by myosin ATPase staining in soleus or
gastrocnemius muscles relative to wild-type controls (Figure 18). Myosin Type-I, Type-IIa, and
Type IIb isoform expression levels were unchanged in gastrocnemius muscle as shown by RTqPCR (Figure 19). SDH assays revealed no differences in the proportion of oxidative myofibers
in gastrocnemius muscle (Figure 20). Myoglobin expression co-localized with SDH enzymatic
activity, further verifying this result (data not shown). Genes involved in fatty-acid metabolism
also showed no changes in expression (Figure 21). These genes include: Acc2, CD36, Cox8b,
Cpt-1, Ppar-a, Ppar-g, UCP2 and UCP3. Furthermore, Glut4 expression remained unchanged.
These results indicate that the traditional adaptations that accompany enhanced exercise
endurance are not found in Myog-deleted mice.

Section 2.5 – Mice lacking myogenin do not consume more food

To test whether the enhanced exercise endurance of Myog-deleted mice is associated
with increased dietary consumption, food weight was measured daily. During a 9-day period of
inactivity, Myog-deleted mice consumed normal amounts of food relative to wild-type control
mice. Similarly, during a 5-day period of daily treadmill running, Myog-deleted mice consumed
normal amounts of food (Figure 22). These results suggest that Myog-deleted mice do not
require increased dietary consumption to maintain their enhanced exercise capacity.

Section 2.6 - The hypoglycemic state abolishes the enhanced exercise endurance of mice lacking
myogenin
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Figure 18 – Myog-deleted mice exhibit normal proportions of Type-I and Type II-fibers in
soleus muscle. Myosin ATPase staining was used to identify Type-I and Type-II fibers in the
soleus muscle (images, left). Average quantitated values reveal normal proportions of these
fiber types (graph, right). Myog-deleted n=3 (253 myofibers/section), wild-type n=3 (180
myofibers/section). Blue bars indicate wild-type control values; red bars indicate Myog-deleted
values. Error bars represent one standard deviation.
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Figure 19 – Myog-deleted mice exhibit normal expression of major myosin isoforms in
gastrocnemius muscle. Taqman RT-qPCR reveals no changes in the expression of Myosin
Type-I, Type-IIA, or Type-IIB. Blue bars indicate wild-type control values; red bars indicate
Myog-deleted values. Error bars represent one standard deviation.
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Figure 20 – Myog-deleted mice exhibit no difference in SDH activity in gastrocnemius.
Succinate Dehydrogenase (SDH) staining was used to identify oxidative fibers in the medial
gastrocnemius (images, left). Average quantitated values reveal normal oxidative activity
(graph, right). Blue bars indicate wild-type control values; red bars indicate Myog-deleted
values. Error bars represent one standard deviation.
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Figure 21 – Myog-deleted mice exhibit normal expression of fatty-acid metabolism genes in
gastrocnemius muscle. Taqman RT-qPCR of selected genes that play a role in fatty-acid
metabolism. No significant changes in gene expression were detected in gastrocnemius muscle
of Myog-deleted mice. These genes include: Acc2 (Acetyl-Coenzyme A carboxylase beta,
Involved in the biosynthesis of fatty acids), CD36 (Cluster of Differentiation 36, Involved in
fatty acid and glucose metabolism), Cox8b (Cytochrome C oxidase subunit 8b, Mitochondrial
electron transport chain, oxidative ATP production), Cpt-1 (Carnitine Palmitoyltransferase I,
Involved in transport of long chain fatty acids across mitochondrial membrane), Glut4 (Glucose
Transporter Type 4, Glucose uptake), Ppar-a (Peroxisome Proliferator-Activated Receptor
Alpha, Nuclear receptor, Regulates fatty acid storage and glucose metabolism), Ppar-g
(Peroxisome Proliferator-Activated Receptor Gamma, Nuclear receptor, Regulates fatty acid
storage and glucose metabolism), UCP2 (Mitochondrial Uncoupling Protein 2, Involved in
oxidative phosphorylation) and UCP3 (Mitochondrial Uncoupling Protein 3, Involved in
oxidative phosphorylation). Blue bars indicate wild-type control values; red bars indicate
Myog-deleted values. Error bars represent one standard deviation.
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Figure 22 – Myog deleted mice do not consume more food
During a 9-day period of inactivity and a 5-day period of treadmill running, Myog-deleted mice
consumed similar amounts of food compared to wild-type control mice. Food consumption
reported as average amount consumed per day, normalized to body weight. Blue bars indicate
wild-type control values; red bars indicate Myog-deleted values. Error bars represent one
standard deviation.
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Myog-deleted were subjected to a 96-hour fast and exercised daily with the high-intensity
protocol to exhaustion. As expected in the fed state, Myog-deleted mice initially ran 1.6-fold
farther than wild-type control mice. After 24 hours of fasting, Myog-deleted mice continued to
outperform wild-type control mice by 2.2-fold. By 48, 72, and 96 hours, Myog-deleted mice no
longer significantly outperformed wild-type mice, running 1.4-fold, 1.4-fold, and 0.9-fold of
controls, respectively. Ten days after the mice were returned to their normal diet, Myog-deleted
mice again significantly outperformed wild-type control mice by 1.5-fold (Figure 23). Myogdeleted mice exhibited similar weights to wild-type control mice throughout the experiment
(data not shown).
Blood lactate and glucose values were measured daily before and after exhaustion during
48, 72, and 96 hours of fasting. At 96 hours, blood lactate levels at exhaustion in Myog-deleted
mice were nearly identical to wild-type (6.1 mM and 6.12 mM, respectively) (Figure 24).
Similarly, blood glucose levels at 96 hours were not significantly different before (Myog-deleted
75 mg/dL, Wild-type 73 mg/dL) or after exercise exhaustion (Myog-deleted 88 mg/dL, Wildtype 72 mg/dL) (Figure 25). Similar blood lactate and blood glucose values before and after
exhaustion after 96 hours of fasting, along with similar exercise capacity, support the idea that
enhanced glycolytic flux is associated with enhanced exercise capacity. These results
demonstrate that Myog-deleted mice require fed-state blood glucose levels in order to exhibit
enhanced exercise capacity.

Section 2.7 - Mice lacking myogenin do not voluntarily run more than wild-type during runningwheel exercise
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Figure 23 – Myog-deleted mice do not run more than wild-type mice during high-intensity
running in the fasted state. Mice were subjected to high-intensity exercise before, during, and
after a 96-hour fast. Under normal dietary conditions, Myog-deleted mice ran approximately
1.5-fold more than wild-type control mice. After 24-hours of fasting, Myog-deleted animals ran
2-fold more than wild-type control mice. By 96-hours of fasting, Myog-deleted mice
completely lost their enhanced exercise endurance. Restoration of normal diet restores the
enhanced exercise endurance of Myog-deleted mice within 10 days. The daily increase in
running distance between 24- and 72-hours is concomitant with a daily loss of 10% body mass
(data not shown). Blue line indicates wild-type control values; red line indicates Myog-deleted
values; green line indicates fold change of Myog-deleted values relative to wild-type values.
Error bars represent one standard deviation. *p<0.05
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Figure 24 – Myog-deleted mice have normal blood lactate levels after high-intensity running in
the fasted state. After a 96-hour fast, Myog-deleted mice and wild-type mice have similar blood
lactate levels after high-intensity exercise (6 mM). Blue bar indicates wild-type control values;
red bar indicates Myog-deleted values. Error bars represent one standard deviation.
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Figure 25 – Myog-deleted mice have normal blood glucose levels after high-intensity running in
the fasted state. After a 96-hour fast, Myog-deleted mice and wild-type mice had similar,
hypoglycemic, blood glucose levels prior to exercise (Myog-deleted 75 mg/dL, wild-type 73
mg/dL). After high-intensity exercise exhaustion, Myog-deleted and wild-type mice had similar
blood glucose levels (Myog-deleted 88 mg/dL, wild-type 72 mg/dL). Blue bars indicate wildtype control values; red bars indicate Myog-deleted values. Error bars represent one standard
deviation.
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Enhanced involuntary exercise endurance may be due to increased fatigue resistance or the
tendency for increased physical activity. To determine whether Myog-deleted mice exhibit the
tendency for increased physical activity, voluntary running capacity was measured. Myogdeleted mice were allowed unrestricted access to running wheels (Figure 26). Over a period of
5 months, Myog-deleted mice did not run significantly farther than wild-type mice on running
wheels allowed to rotate freely (Myog-deleted 7.4 km/day, Wild-type 8.2 km/day) (Figure 27A).
Myog-deleted mice also ran similar average and maximum speeds compared to wild-type mice
(Figure 27B, C). A 1 kg load was then applied to the axis of the running wheels to increase the
turning resistance. Under a loaded state, Myog-deleted mice did not run significantly farther
than wild-type mice (Myog-deleted 9.1 km/day, Wild-type 6.9 km/day) (Figure 27). Myogdeleted mice also ran similar average and maximum speeds compared to wild-type mice when
the running wheel resistance was added (Figure 27B, C). The lack of significantly increased
running capacity during voluntary exercise indicates that the lack of myogenin does not confer
an increased tendency for exercise.

Section 2.8 - Superior adaptation to exercise training in mice lacking myogenin

To determine whether Myog-deleted mice are abnormally affected by exercise training,
mice that were allowed unrestricted access to voluntary running wheels for 6 months (herein
referred to as “trained mice”) were subjected to high-intensity involuntary exercise running.
Wild-type mice exhibited a significant response to exercise training with a 1.8-fold increase in
exercise capacity during high-intensity treadmill running (Untrained wild-type 382 meters/day,
Trained wild-type 696 meters/day). Myog-deleted mice also exhibited a significant response to
exercise training with a 2.2-fold increase in exercise capacity (Untrained Myog-deleted 599
meters/day, Trained Myog-deleted 1324 meters/day) (Figure 28). Comparative analysis of wild66

Figure 26 – The Klein Lab Voluntary Exercise Running Wheel
To facilitate long-term exercise training, we custom built a voluntary running wheel apparatus
that allowed for measurements of average speed, maximum speed, distance, and time. See
Methods Chapter for more information.
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Figure 27 – Trained Myog-deleted mice do not voluntarily run farther or faster than trained
wild-type mice. After the deletion of Myog, Myog-deleted and wild-type mice were allowed
unrestricted access to voluntary running wheels for 6 months. At 4-5 months, trained Myogdeleted mice ran similar amounts as trained wild-type mice on running wheels were allowed to
rotate freely (Myog-deleted 7.4 Km/day, wild-type 8.2 Km/day) (Figure 27A). At 6 months,
trained Myog-deleted mice ran similar amounts as trained wild-type mice when a 1 kg load was
added to the running wheel axis (Myog-deleted 9.1 Km/day, wild-type 6.9 Km/day) (Figure
27B). Additionally, no changes were observed in average speed (27B) or maximum speed
(27C) during this time. Blue bars indicate wild-type control values; red bars indicate Myogdeleted values. Error bars represent one standard deviation.
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Figure 28 – Superior adaptation to exercise training in mice lacking myogenin.
After exercise training (trained) or during sedentary life (untrained), Myog-deleted and wildtype mice were subjected to >12 days of high-intensity treadmill running. Trained wild-type
mice showed a typical adaptation to exercise training, running an average 1.8-fold more than
untrained wild-type mice (untrained wild-type 382 meters, trained wild-type 696 meters).
Trained Myog-deleted mice showed a superior adaptation to exercise training, running an
average 2.2-fold more than untrained Myog-deleted mice (untrained Myog-deleted 599 meters,
trained Myog-deleted 1324 meters). Trained Myog-deleted mice exhibit a 20% increase in their
adaptive response to training relative to trained wild-type mice. Untrained wild-type n=7,
untrained Myog-deleted n=8, trained wild-type n=10, trained Myog-deleted n=11. Blue bars
indicate wild-type control values; red bars indicate Myog-deleted values. Error bars represent
one standard deviation. *p<0.05, **p<0.01
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type and Myog-deleted groups reveals that Myog-deleted mice respond 20% better to exercise
training than wild-type. These results indicate that Myog-deleted mice are more sensitive to
long-term exercise-induced training adaptations.

Section 2.9 - Lack of myogenin during long-term exercise training increases slow-twitch fibertype proportion and oxidative capacity of skeletal muscle

Histological sections from trained Myog-deleted and wild-type mice were analyzed with
Myosin-ATPase and succinate dehydrogenase (SDH) assays. Myosin-ATPase staining revealed
that training mildly increases the proportion of Type-I slow-oxidative fibers in the soleus
muscle. Trained Myog-deleted mice showed a more robust 78% increase in the proportion of
Type-I fibers. Gastrocnemius muscle showed similar changes (data not shown). Indeed, trained
Myog-deleted mice show a 30% increase in the proportion of Type-I fibers when compared to
trained wild-type mice (Figure 29).
SDH activity in gastrocnemius muscle revealed that exercise training dramatically
increases SDH levels in wild-type mice from 6 SDH-fibers/mm2 to 140 SDH-fibers/mm2.
Trained Myog-deleted mice also showed a dramatic increase in SDH enzymatic activity from 11
SDH-fibers/mm2 to 234 SDH-fibers/mm2. Comparison of trained Myog-deleted and trained
wild-type SDH-fiber density revealed a 70% increase in SDH enzymatic activity in trained
Myog-deleted mice (Figure 30). Myoglobin expression co-localized with SDH enzymatic
activity, further verifying this result (data not shown). The increased proportion of Type-I fibers
and SDH enzymatic activity indicates that Myog-deleted mice are more prone to histologic
changes associated with exercise training.
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Figure 29 – Trained Myog-deleted mice exhibit an increase in Type-I slow-twitch fibers in
soleus muscle. Myosin ATPase staining was used to identify Type-I and Type-II fibers in the
soleus muscle of untrained and trained mice (images, left). Average quantitated values reveal a
22% increase in Type-I fibers in trained wild-type mice (untrained wild-type 50%, trained wildtype 61%); trained Myog-deleted mice exhibited a 93% increase in the proportion of Type-I
fibers (untrained Myog-deleted 41%, trained Myog-deleted 79%) (graphs, right). Trained Myogdeleted mice exhibited a 30% increase in the proportion of Type-I fibers relative to trained wildtype mice. Blue bars indicate wild-type control values; red bars indicate Myog-deleted values.
Error bars represent one standard deviation. *p<0.05
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Figure 30 – Trained Myog-deleted mice exhibit an increase in Succinate Dehydrogenase enzyme
activity in gastrocnemius muscle. Succinate Dehydrogenase (SDH) staining was used to
identify oxidative fibers in the gastrocnemius of untrained and trained mice (images, left).
Average quantitated values reveal a 23-fold increase in SDH-positive fibers in trained wild-type
mice (untrained wild-type 6 SDH fibers/mm2, trained wild-type 140 SDH fibers/mm2); trained
Myog-deleted mice exhibited a similar 21-fold increase in SDH-positive fibers (untrained Myogdeleted 11 SDH fibers/mm2, trained Myog-deleted 234 SDH fibers/mm2) (graphs, right).
Trained Myog-deleted mice exhibited a 67% increase in SDH-positive fiber density relative to
trained wild-type mice. Blue bars indicate wild-type control values; red bars indicate Myogdeleted values. Error bars represent one standard deviation. *p<0.05
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Section 2.10 - Myogenin regulates the expression of genes involved in metabolism and signal
transduction during adult life

A gene expression profiling study was next performed to identify changes in global gene
expression due to Myog deletion during adult life. Total RNA from trained Myog-deleted and
wild-type mice was extracted from gastrocnemius muscles and used for Affymetrix microarray
analysis. The analysis revealed differential expression of 29 downregulated genes and 11
upregulated genes that significantly changed >1.4-fold. Changes in global gene expression
patterns were enriched for genes involved in signal transduction and metabolism (Table 1).
Thirteen genes were chosen for validation of gene expression changes by Taqman RT-qPCR
analysis (Figure 31). These genes include: RhoBTB1, Rhpn2, Htra1, Gpx3, Pcx, Nfatc2,
Zscan21, Bmp5, Mpa2l, Bdh, Pfkfb3, and Dpyd. Gene expression profiling indicates that while
Myog-deleted mice appear normal, their enhanced exercise endurance is associated with global
gene expression changes.

Section 2.11 - Myogenin is not essential for viability in adult mdx mice

To explore the role of myogenin in functionally compromised skeletal muscle, mice
carrying the conditional alleles of Myog were bred with dystrophin-deficient (mdx) mice. The
mice were then injected with tamoxifen to delete Myog. Control mice with functional
dystrophin were also generated (Figure 32). Upon deletion of Myog from mdx mice between 3
and 5 months of age, no phenotypic differences were observed over a period of 6 months.
Double knockout mice maintained healthy body weight and exhibited normal mobility relative
to wild-type control mice. These results indicate that Myog is not essential for viability in
young adult mice lacking dystrophin.
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Figure 31 – Myogenin regulates genes involved in metabolism and signal-transduction during
adult life. Taqman RT-qPCR validation was performed on selected differentially expressed
genes in adult Myog-deleted gastrocnemius muscle. These genes include: RhoBTB1 (Rhorelated BTB domain containing 1, a Rho GTPase), Rhpn2 (Rhophilin, a Rho GTPase binding
protein), Htra1 (a serine peptidase), Gpx3 (glutathione peroxidase 3), Pcx (pyruvate
carboxylase), Nfatc2 (Nuclear factor of activated T-cells 2), Zscan21 (zinc finger and SCAN
domain containing 21), Bmp5 (bone morphogenetic protein 5), Mpa2l (macrophage activation 2
like), Bdh (3-hydroxybutyrate dehydrogenase), Pfkfb3 (phosphofructokinase/fructosebisphosphatase 3), and Dpyd (dihydropyrimidine dehydrogenase). Blue bars indicate wild-type
control values; red bars indicate Myog-deleted values. Error bars represent one standard
deviation. *p<0.05, **p<0.01
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Figure 32 – Dystrophin genotype validation via sequencing
A sequencing plot reveals the nucleotide mutation resulting in dystrophin deficiency in mdx
mice. Wild-type mice carry a cytosine (C) at the indicated nucleotide position. Dystrophin
deficiency in mice is caused by a thymidine (T) substitution at this position, leading to a
premature stop codon (AUA). Given that dystrophin is X-linked, only females may be
heterozygous.
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Table I – Description of selected and validated microarray genes
Gene
Fold
change Regulation Symbol
2.4

down

1.8

down

1.8

down

1.7

down

1.6

down

1.6

down

1.6

down

1.5

down

1.4

up

1.6
1.8

up
up

1.9

up

2.0

up

Gene Title

Rfx7 regulatory factor X, 7
Rho-related BTB domain
Rhobtb1 containing 1
rhophilin, Rho GTPase
Rhpn2 binding protein 2

GO Biological Process Term
regulation of transcription, DNAdependent
small GTPase mediated signal transduction

signal transduction
regulation of transcription, DNAMyog myogenin
dependent
regulation of cell growth /// proteolysis ///
negative regulation of transforming growth
factor beta receptor signaling pathway ///
negative regulation of BMP signaling
Htra1 HtrA serine peptidase 1
pathway
glutathione metabolic process /// response
to oxidative stress /// hydrogen peroxide
catabolic process /// protein
homotetramerization /// protein
homotetramerization /// oxidation
Gpx3 glutathione peroxidase 3
reduction
transcription /// regulation of transcription,
DNA-dependent /// multicellular
organismal development ///
spermatogenesis /// cell differentiation ///
zinc finger and SCAN domain positive regulation of transcription, DNAZscan21 containing 21
dependent /// oogenesis
gluconeogenesis /// oxaloacetate metabolic
process /// metabolic process /// lipid
Pcx pyruvate carboxylase
biosynthetic process
skeletal system development ///
ossification /// multicellular organismal
development /// pattern specification
process /// cell differentiation /// growth ///
Bmp5 bone morphogenetic protein 5 cartilage development
6-phosphofructo-2fructose metabolic process /// fructose 2,6bisphosphate metabolic process ///
kinase/fructose-2,6Pfkfb3 biphosphatase 3
metabolic process
Mpa2l macrophage activation 2 like immune response
'de novo' pyrimidine base biosynthetic
process /// pyrimidine base catabolic
process /// uracil catabolic process ///
thymidine catabolic process /// UMP
dihydropyrimidine
biosynthetic process /// metabolic process
Dpyd dehydrogenase
/// oxidation reduction
3-hydroxybutyrate
Bdh1 dehydrogenase, type 1
metabolic process /// oxidation reduction
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Section 2.12 - Mdx mice exhibit reduced exercise endurance

Although dystrophin-deficient mice appear normal, a phenotypic difference may be uncovered
during exercise. Young adult mdx mice were subjected to a modified high-intensity treadmill
regime to determine whether they are capable of normal exercise duration and more prone to
exercise-induced muscle fatigue relative to wild-type control mice. Over a period of 14
consecutive days, wild-type mice consistently outperformed mdx mice by approximately twofold (Wild-type 527 meters/day, Myog-deleted 272 meters/day) (Figure 33). These results
indicate that the lack of dystrophin in this mixed genetic background causes sufficient muscle
trauma to mdx mice, thereby limiting their exercise endurance.

Section 2.13 - Lack of myogenin in dystrophin-deficient adult mice attenuates reduced exercise
endurance

To determine whether myogenin is necessary in adult mdx mice during periods of
exercise-induced stress, Myog-deleted; mdx double-knockout mice were subjected to the
modified high-intensity exercise regime. Within one week of Myog deletion, double knockout
mice initially exhibited a similar exercise capacity as mdx mice. Over a period of 14
consecutive days, Myog-deleted mice showed a marked improvement in exercise running
performance relative to mdx mice. On average, double knockout mice ran approximately 2-fold
farther than mdx mice, and similar distances as wild-type control mice (Figure 34). These
results indicate that Myog-deletion from young adult mdx mice attenuates their inherently
reduced capacity for exercise.
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Figure 33 – Mdx mice exhibit a reduced exercise capacity
Wild-type and mdx mice were run using a modified high-intensity treadmill protocol for 14
consecutive days. On average, mdx mice ran only 52% of the distance of wild-type mice (Mdx
272 meters, wild-type 527 meters). Blue line and bar indicates wild-type control values; orange
line and bar indicates Mdx values. Error bars represent one standard deviation. *p<0.005
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Figure 34 – Myog deletion from Mdx mice attenuates reduced exercise capacity
While mdx mice ran only 52% of the distance of wild-type mice, Myog-deleted; mdx mice ran
similar distances to wild-type mice (Myog-deleted; mdx 569 meters, wild-type 527 meters).
Blue line and bar indicates wild-type control values; orange line and bar indicates mdx values;
green line and bar indicates Myog-deleted; mdx values). Error bars represent one standard
deviation. *p<0.005

87

88

Chapter 3 - Discussion

Section 3.1 - Myogenin modulates exercise endurance by altering skeletal muscle metabolism

In order to avoid the effects of Myog deletion on postnatal body growth, Myog was
deleted only after mice had reached their adult size. Deletion of Myog from adult mice
demonstrates that Myog is not required for adult viability. Mice lacking Myog fed normally,
maintained normal body weight, and exhibited normal mobility over a 2-year period of
observation. The unremarkable phenotype of sedentary Myog-deleted mice suggests that
myogenin may have redundant functions with other MRFs during adult life. Thus, it is possible
that myogenin expression could be silenced during adult life in sedentary mice without fatal
consequences.
Unexpectedly, mice lacking myogenin are remarkably better at exercise running than
wild-type control mice within two weeks of Myog deletion. Under a low-intensity running
regime, Myog-deleted mice out-performed their wild-type counterparts. While enhanced lowintensity exercise endurance indicated a potential enhancement in the aerobic metabolic
pathways, we failed to find blood metabolite or histological evidence to support this conclusion.
A seemingly enhanced aerobic endurance would typically be accompanied by measureable
changes in fiber type properties, oxidative potential, and altered expression of fatty acid
metabolism genes (Booth and Thomason, 1991). Myog-deleted mice appear to exhibit a better
aerobic endurance without exhibiting the expected changes on the cellular level.
Myog-deleted mice were also better during high-intensity exercise. Subjecting the mice
to uphill running at progressively faster speeds for 12 consecutive days revealed two
phenomena: Myog-deleted mice are remarkably and consistently better than wild-type mice
during high-intensity exercise, and the lack of myogenin does not cause a progressive decrease
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in performance from day-to-day. The consistent exercise performance demonstrates that muscle
maintenance and regeneration occur normally in exercising adult mice lacking myogenin and
suggests that myogenin does not play a critical role during the maintenance of adult skeletal
muscle.
Blood glucose and blood ketone measurements give some insight into why Myog-deleted
mice have increased exercise endurance during exercise. Typical adaptations to endurance
exercise involve a more efficient utilization of fatty acids while efficiently conserving muscle
and liver glycogen stores (Booth and Thomason, 1991). Once muscle and liver glycogen stores
are depleted, exercise performance sharply declines due to the inability of fatty acid metabolism
to efficiently keep up with the ATP demands of the body (Fitts, 2004). In addition, the brain
preferentially uses glucose for efficient function. Marathon runners who deplete their glycogen
stores and experience this performance decline before finishing the race call this point “the
wall” (Coyle, 2007). While the depletion of muscle and liver glycogen (as shown by blood
glucose depletion) and the enhancement of exercise endurance could be independent of each
other, Myog-deleted mice are nonetheless capable of exercise as blood glucose levels drop
significantly below levels normally associated with exhaustion. Ketone bodies are typically
produced in response to excess blood glucose depletion to provide an alternative source of fuel
for the brain. Although Myog-deleted mice showed only a trend towards elevated blood ketone
body production after low-intensity exercise, it further supports the conclusion that Myogdeleted mice are excessively using blood glucose. The ability to deplete muscle and liver
glycogen stores while continuing to exercise suggests that Myog-deleted mice have a higher
exhaustion threshold and can push beyond “the wall”. The reduction of blood glucose during
low- and high-intensity exercise suggests that the lack of myogenin allows trained Myog-deleted
mice to preferentially use muscle and liver glycogen stores as a source of energy for longer
periods and indicates an enhanced glycolytic flux.
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Blood lactate gives further insight into the increased exercise endurance and fatigue
resistance of Myog-deleted mice. Blood lactate levels traditionally build as exercise intensity
increases (Gladden, 1996). The concentration of lactate in the blood is directly associated with
exercise fatigue and has been long argued to be a contributing factor. During high-intensity
exercise, blood lactate levels in Myog-deleted mice are dramatically increased beyond their
baseline values after wild-type mice reach exhaustion. The excessive production of blood
lactate during the later stages of exercise indicates that Myog-deleted mice heavily rely on the
glycolytic pathway for energy demand and that blood lactate does not limit their exercise
endurance. Indeed, as others have shown, lactate may actually enhance exercise performance
and contribute to the enhanced exercise performance of Myog-deleted mice (Allen and
Westerblad, 2004; Allen et al., 2008; Pedersen et al., 2004). Myog-deleted mice may ultimately
reach exhaustion under high-intensity exercise due to the acidosis associated with extreme lactic
acid production. Acidosis likely limits exercise performance during high-intensity exercise
before blood glucose is excessively depleted as it is during low-intensity exercise. Indeed,
blood lactate levels are unchanged following low-intensity exercise, suggesting the efficient
metabolism of lactate through the Cori Cycle. These results suggest that the extreme exercise
performance of Myog-deleted mice is ultimately governed by the availability of liver- and
muscle-glycogen stores and by the performance-enhancing effects of lactate. A decreased
sensitivity to the depletion of glycogen reserves and the ability to withstand extreme muscle
acidosis may ultimately enhance exercise endurance.
An increased glycolytic flux in Myog-deleted mice suggests that carbohydrate depletion
may adversely affect their exercise endurance. Indeed, when Myog-deleted mice were fasted for
a period of 96 hours, they completely lost their enhanced exercise endurance compared to wildtype mice. Blood glucose measurements indicate that both wild-type and Myog-deleted mice
were hypoglycemic prior to exercise at 96 hours, and measurements at exhaustion remained
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similar to pre-exercise levels in both groups. These data suggest that the reduction in preexercise blood glucose dramatically decreased the glycolytic flux in Myog-deleted mice during
exercise. Likewise, exhausted Myog-deleted mice displayed similar blood lactate levels as
exhausted wild-type mice after the 96-hour fast. Upon returning the mice to their normal diets,
Myog-deleted mice recovered their enhanced exercise endurance within 10 days. These results
suggest that the enhanced exercise endurance of Myog-deleted mice is due to an increased
dependence on muscle and liver glycogen as a source of energy.
In addition to myogenin, other investigators have discovered factors that influence
exercise capacity. The over-expression of phosphoenolpyruvate carboxykinase (PEPCK) in
skeletal muscle increases cage activity and treadmill exercise capacity in mice by repatterning
energy metabolism (Hakimi et al., 2007). These mice also exhibited a higher oxygen
consumption, increased food intake, decreased body weight, and increased mitochondria in their
muscle. Overall, PEPCK over-expression increases the citric acid cycle flux to generate more
energy for muscle contraction during strenuous exercise. On the other hand, mice overexpressing PPAR-delta in skeletal muscle demonstrate enhanced exercise performance by an
increase in slow-twitch fiber composition (Wang et al., 2004). PPAR-delta is a transcription
factor involved in regulation of fat burning in adipose tissue and muscle fiber specification. The
transcriptional co-activator PGC-1 alpha also drives slow-twitch fiber formation. PGC1-alpha
is expressed in brown fat and skeletal muscle and activates mitochondrial biogenesis (Wu et al.,
1999). Furthermore, oxidative metabolism genes are activated when PGC1-alpha is expressed
in fast-twitch muscle fibers (Lin et al., 2002). The transformation of fiber type characteristics
involves cooperation with Mef2 proteins and calcineurin signaling (Olson and Williams, 2000).
Acting through calcineurin signaling, Calsarcin-2, a muscle-specific protein of the sarcomeric
Z-disk, modulates exercise performance and alters skeletal muscle fiber type composition (Frey
et al., 2008). Together, enhanced exercise performance is associated with alterations in
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mitochondrial activity, muscle fiber specification, and calcium signaling. The enhanced
exercise endurance of Myog-deleted mice may involve pathways that are independent of the
pathways described above.
As the innervation of muscle largely determines its fiber type composition, the
denervation of Myog-deleted mice gives some insight into which pathways myogenin is
involved. Myog expression is induced upon muscle denervation and this induction requires
HDAC4 activity (Tang and Goldman, 2006). After denervation, Myog and HDAC4
differentially regulate genes involved in muscle fiber type specification, positively regulating
oxidative gene expression while suppressing glycolytic gene expression (Tang et al., 2009). In
addition to gene expression changes induced by denervation, denervation also induces muscle
atrophy (Jackman and Kandarian, 2004). Myogenin plays an unexpected role as an essential
activator of muscle atrophy, and its deletion during adult life suppresses muscle atrophy after
denervation (Moresi V., 2010). After denervation, myogenin activates skeletal muscle E3
ubiquitin ligases (MuRF1 and atrogin-1), which mediate muscle proteolysis and atrophy. These
results indicate that the expression of Myog and glycolytic genes is mutually exclusive and that
the deletion of Myog during adult life may relieve the HDAC4-mediated suppression of
glycolytic genes, thus enhancing glycolytic flux in Myog-deleted mice (Figure 36).
Furthermore, the ability of Myog-deleted mice to resist muscle atrophy after denervation
suggests that Myog-deleted mice may be resistant to muscle damage after exercise-induced
injury.
To summarize, adult mice lacking myogenin exhibit an enhanced exercise capacity
associated with increased blood glucose utilization and excessive lactate production. These
changes are completely abolished when mice reach a hypoglycemic state during a 96-hour fast.
This enhanced exercise endurance is not associated with a change in myosin ATPase fiber type,
myosin isoform expression, myofiber oxidative potential, the metabolism of fatty acids, or
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increased dietary consumption. The ability to shift the metabolic activity of skeletal muscle
fibers without a change in myosin heavy chain expression is well documented (Hughes et al.,
1999; Kiens et al., 1993; Schluter and Fitts, 1994). As fiber-type switching is more of a longterm adaptation, changes in metabolic activity in Myog-deleted mice are likely responsible for
the enhanced exercise capacity observed within 2-weeks of Myog deletion. Notably, the overexpression of myogenin shifts the muscle enzymatic activity from glycolytic towards oxidative
metabolism, independent of a change in fiber type (Hughes et al., 1999). While the presence of
myogenin leads to increased oxidative enzyme activity and mediates the effect of innervation on
slow-twitch muscle fibers (Hughes et al., 1993), the absence of myogenin may provide a less
oxidative (more glycolytic) environment. Together, these results suggest that the enhanced
exercise capacity of Myog-deleted mice is not due to changes traditionally associated with
enhanced exercise capacity but the result of enhanced glycolytic flux.
This study is the first to demonstrate both a positive effect of removing a MRF during
adult life and a phenomenon involving a shift from oxidative towards glycolytic metabolism.
The ability of mice lacking myogenin to outperform wild-type mice during exercise running
raises a seemingly paradoxical question: Why does myogenin expression persist in adult
skeletal muscle? These results suggest that myogenin is not required and that the deletion of
Myog is actually advantageous to exercise endurance. Two potential explanations for myogenin
expression during adult life are offered:

1.) Myogenin may be more highly expressed in populations of mice that are dependent on
environmental adaptations. Over many years and generations away from natural
predators, laboratory mice may experience less selective pressure towards the adulthood
silencing of myogenin, thus leading to the increased development of slow-oxidative
fibers. Myogenin may exhibit lower levels of expression in some wild populations of
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mice that evolved in heavily wooded areas, where sprinting to avoid predators may be
an evolutionary advantage. The ability to sprint would be enhanced by the increased
glycolytic enzyme activity due to the loss of myogenin.
2.) Myogenin is essential throughout adult life. While the deletion of Myog confers
enhanced exercise endurance, this phenotype is not without an excessive depletion of
blood glucose. The body’s natural ability to sense hypoglycemia and react by ceasing
exercise activity would likely prove more beneficial in most environments, given that
long-term effects of hypoglycemia increase overall morbidity and mortality (Fischer et
al., 1986; Service, 1995). While we did not detect an increased morbidity and mortality
associated with Myog-deleted mice after exercise exhaustion, environmental pressure
may be required to witness this selection. The presence of myogenin during adult life
may contribute to feedback mechanisms ultimately allowing the body to cease excessive
skeletal muscle activity in favor of blood glucose conservation.

Section 3.2 – The lack of myogenin enhances adaptation to exercise training

While determining that Myog-deleted mice have enhanced exercise endurance during
involuntary treadmill running, we also tested their voluntary exercise capacity. Although we
were not able to detect that mice lacking myogenin voluntarily run more, the mice used in this
experiment gave additional insight into this phenotype. Given that Myog-deleted mice run
similar distances and speeds as wild-type mice during voluntary exercise, their will and capacity
to perform under voluntary exercise is unaffected by the loss of myogenin. Indeed, lowintensity, voluntary exercise would most certainly not stress glycolytic pathways or blood
glucose levels (Allen et al., 2001).
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Over a 6-month period, wild-type and Myog-deleted mice were allowed unrestricted
access to voluntary exercise. During this training period, wild-type mice are expected to exhibit
long-term adaptations to exercise, such as fiber-type changes, increased mitochondria density
and activity, and enhanced vasculature. Fast- to slow-twitch fiber-type transition and increased
oxidative capacity are well-documented, long-term adaptive responses to exercise training
(Baldwin et al., 1977; Baldwin et al., 1972; Dudley et al., 1982; Holloszy et al., 1970; Ishihara
et al., 1991; Rodnick et al., 1989; Sexton, 1995). Indeed, these changes were quite apparent in
trained wild-type mice, which exhibited enhanced exercise endurance when they were retested
with involuntary high-intensity exercise. Suprisingly, trained Myog-deleted mice exhibited a
superior adaptive response to exercise training under similar conditions. In addition, untrained
(sedentary) Myog-deleted mice had similar exercise endurance as trained wild-type mice. This
suggests that merely silencing myogenin expression during adult life confers the same exercise
endurance obtained after long-term exercise training. The effect of exercise training and
deletion of myogenin on exercise performance appears to be a synergistic effect as trained
Myog-deleted mice have a nearly 4-fold enhanced exercise capacity over untrained wild-type
mice.
The enhanced exercise endurance of trained wild-type mice is associated with a mild
increase in slow-twitch fiber-type proportion and a dramatic increase in succinate
dehydrogenase (SDH)-positive fibers. The superior exercise endurance of trained Myog-deleted
mice is associated with a comparatively higher proportion of both slow-twitch fibers and SDHpositive fibers than trained wild-type control mice. These changes indicate a typical response to
training in trained wild-type mice and an enhanced response to training in trained Myog-deleted
mice. The increased proportion of the slow-twitch fibers and oxidative capacity allow trained
Myog-deleted mice the ability to efficiently conserve muscle and liver glycogen stores by more
efficiently utilizing fatty acids during low-intensity exercise. As exercise intensity progresses,
96

the more efficient glycolytic flux of Myog-deleted mice may better support the energy demands
of high-intensity exercise. It is also likely that the ability of Myog-deleted mice to excessively
deplete their glucose reserves supports the high-energy demands of high-intensity exercise. The
dramatic changes in fiber type and SDH enzyme activity support the conclusion that Myogdeleted mice respond better to training than wild-type mice.
Because myogenin functions as a transcription factor, changes in gene expression would
be expected following its deletion. Indeed, genes involved in signal transduction and
metabolism were altered in trained Myog-deleted mice when compared to trained wild-type
mice. Gene expression changes of particular interest include: Gpx3, Pcx, Bdh, and Pfkfb3.
Gpx3 (Glutathione peroxidase 3) is a primary antioxidant enzyme, which has been suggested to
potentially improve exercise performance and delay muscle fatigue (Powers et al., 1999). Given
that Gpx3 is downregulated 30% in mice lacking myogenin, Myog-deleted mice may be more
prone to long-term oxidative stress while exhibiting enhanced exercise performance. Pcx
(Pyruvate Carboxylase) is involved in the first step of gluconeogenesis and plays a major role in
both carbohydrate and lipid metabolism (Jitrapakdee et al., 2008). The 20% downregulation of
Pcx in mice lacking myogenin may offer insight into why Myog-deleted mice have increased
glycolytic activity. Pcx catalyzes an anaplerotic reaction, replenishing oxaloacetate within the
citric acid cycle to maintain efficient oxidative metabolism. A reduction in Pcx activity may
enhance glycolytic metabolism by partially shunting pyruvate away from the citric acid cycle,
thus contributing to the increase in blood lactate levels. Currently, there are no known
references to such a phenomenon, and Pcx deficiency is typically detrimental (Jitrapakdee et al.,
2008). Bdh (3-hydroxybutyrate-dehydrogenase) is involved in the process of ketone body
production (Owen et al., 1967). The 50% increase in Bdh expression in mice lacking myogenin
may be a result of decreased blood glucose availability to the brain. Given that the brain
switches to ketone bodies for energy when blood glucose is low, this could be a compensatory
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effect. Pfkfb3 (Phosphofructokinase / Fructose-bisphophatase) is a gene involved in a ratelimiting, reversible step of the glycolytic pathway (Minchenko et al., 2003; Yalcin et al., 2009).
Pfkfb3 encodes a muscle-specific protein called Pfk2, which regulates the activity of Pfk1, and
ultimately regulates glycolytic flux. Although Pfk2 is a dual activity enzyme, promoting both
glycolysis and gluconeogenesis, this particular isoform has a 400:1 tendency to enhance
glycolytic flux in skeletal muscle (Yalcin et al., 2009). The 80% increase in Pfkfb3 expression
in mice lacking myogenin may be involved in the mechanisms conferring enhanced exercise
capacity. Indeed, myogenin has been previously shown to indirectly inhibit genes involved in
the glycolytic pathway (Tang et al., 2009). Together, these results suggest that glycolytic
metabolism may be partially enhanced by Myog deletion, mediated through a release of Pfkfb3
inhibition (Figure 35).
While some of these changes in gene expression may require exercise training, they are
nonetheless changed due to myogenin’s absence. Mild changes in gene expression for any one
or more of these genes may sufficiently alter the metabolic properties of skeletal muscle to
confer enhanced exercise endurance. It is unclear how an enhanced glycolytic metabolism (i.e.
the ability to preferentially use glycogen stores during exercise training) leads to increased
proportion of slow-twitch fibers and oxidative capacity in trained Myog-deleted mice. Although
the over-expression of myogenin in fast-twitch muscle increases oxidative enzyme activity
(Hughes et al., 1999), the absence of myogenin does not appear to leave mice with an inferior
oxidative capacity. While myogenin has been shown to mediate the effects of innervation on
slow-twitch muscle fiber formation (Hughes et al., 1993), other factors clearly play similar roles
during the exercise training of mice lacking myogenin. The absence of myogenin during
periods of long-term exercise training may provoke compensatory pathways that also mediate
the effects of slow-twitch fiber formation and increased oxidative metabolism.
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Figure 35 – Potential Mechanism
Myogenin positively regulates the expression of oxidative metabolism genes (Hughes et al.,
1999; Hughes et al., 1993; Tang et al., 2009) and represses glycolytic metabolism genes through
HDAC4 activity. Pfkfb3, a glycolytic gene involved in a rate-limiting step of glycolysis,
converts F6P to F2,6BP, which positively regulates the activity of PFK-1. PFK-1 is a dualactivity enzyme that interconverts F6P and F1,6BP, directly regulating glycolytic flux. Pfkfb3
expression may be upregulated in the absence of myogenin, thereby increasing PFK-1 activity
and enhancing glycolytic flux.
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Overcompensation by one or more deregulated genes in this pathway could explain how
exercise training not only induces the formation of slow-oxidative fibers but also enhances this
adaptive response.
In summary, trained Myog-deleted mice exhibit a better adaptive response to exercise
training because of their ability to selectively use, and excessively deplete, liver and muscle
glycogen stores during exercise. Changes in global gene expression due to myogenins absence
may play a role in mediating the innervation-dependent formation of slow-oxidative fibers
during exercise training. These traits allow trained Myog-deleted mice to reach exercise
intensities beyond normal physical limitations. The identification of Myog-dependent genes and
pathways during adult life is an aim of Project II.

Section 3.3 – The lack of myogenin attenuates muscle fatigue associated with muscular
dystrophy

Muscular dystrophy is a condition characterized by progressive muscle weakness and
muscle wasting, ultimately resulting in early mortality (Blake et al., 2002). The progressive
muscle weakness in mice lacking dystrophin makes them ideal to test whether myogenin is
required during adult life. Mdx mice exhibited no phenotypic difference during sedentary life
and were seemingly normal. Although dystrophin-deficiency results in a varying degree of
strain-dependent mouse phenotypes, increased muscle fatigue was successfully demonstrated in
mdx mice during treadmill running. Mdx mice were capable of exercise for only 50% of total
exercise time compared wild-type control mice. Overall, dystrophin was not essential for a
sedentary lifestyle in mdx mice yet was necessary for normal exercise endurance.
Deleting myogenin from mdx mice allowed us to test the necessity of myogenin in
structurally weakened and dysfunctional skeletal muscle. Given that muscle function is
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compromised at the cytoskeletal level in mdx mice, myogenin was hypothesized to be essential
for the maintenance of many other critical skeletal muscle structural proteins. However, the
deletion of Myog from young adult mdx mice did not affect their mobility or ability to feed.
This result indicates that myogenin is not required for sedentary muscle function or viability in
mdx mice. When mdx mice lacking myogenin were initially subjected to treadmill running,
these double-knockout mice had similar exercise endurance as mdx mice. Unexpectedly, over a
14-day period we observed an attenuation of the reduced exercise endurance associated with
dystrophin deficiency. The deletion of myogenin not only had immediate positive effects on
muscle fatigue, but also consistently maintained this trend during two weeks of exhaustive
exercise.
Interestingly, fast glycolytic muscle fibers have a 50% reduction in phosphofructokinase
activity in human patients with muscular dystrophy (Chi et al., 1987). Similarly, loss of
phosphofructokinase activity contributes to defects in glycolysis and increased fatigability in
mice with muscular dystrophy (Wehling-Henricks et al., 2009). When phosphofructokinase
activity is artificially increased in the skeletal muscle of mdx mice, glycogen metabolism is
enhanced concomitantly with increased exercise endurance. Deletion of Myog from our mdx
mice may offset their inherent glycolytic dysfunction. This effect may be partly mediated
through an upregulation of phosphofructokinase expression as a consequence of Myog deletion.
Thus, the loss of myogenin may ultimately result in a partial rescue of fatigability and exercise
endurance in mice with muscular dystrophy. These data suggest that the modulation of
myogenin expression during young adult life in humans may provide another avenue for
muscular dystrophy therapy development.
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PROJECT II

Myogenin target gene activation in adult muscle stem cells
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Chapter 4 - Introduction
Myogenesis coordinates skeletal muscle formation and accretion, which begins during
embryonic life and ends postnatally after an animal reaches adulthood. The maintenance and
repair of skeletal muscle during adult life recapitulates the process of embryonic skeletal muscle
development, and is coordinated by adult satellite stem cells (Charge and Rudnicki, 2004; Cossu
and Molinaro, 1987; Gibson and Schultz, 1983; Schultz et al., 1985). Satellite stem cells reside
along myofibers and are activated by signals during postnatal growth, muscle repair, and muscle
maintenance. Muscle stem cell differentiation is a process that is tightly controlled primarily by
MRFs (Figure 1). MRFs dimerize with the ubiquitous E12/E47 proteins and bind to E-box
motifs present within the transcriptional control regions (TCR) of skeletal muscle-expressed
genes. These genes must be activated for the proper development of skeletal muscle. MRF
proteins cooperate with MEF2 proteins to efficiently activate the expression of skeletal muscleexpressed genes (Black and Olson, 1998).
Significant progress has been made towards distinguishing the individual MRF family
members. While many functions of individual MRFs are functionally redundant, each MRF is
efficiently expressed during muscle stem cell proliferation and differentiation and is conserved
among vertebrate animals (Sabourin and Rudnicki, 2000). Quiescent muscle stem cell
activation and proliferation primarily involves the activity of MyoD, Myf5, and Mrf4. Myoblast
differentiation into myofibers involves the activity of MyoD, myogenin, and Mrf4 (Berkes and
Tapscott, 2005; Charge and Rudnicki, 2004) (Figure 1). Mild phenotypes are observed with the
single knockouts of MyoD, Myf5, and Mrf4, but the knockout of Myog severely disrupts
myoblast differentiation and the subsequent formation of skeletal muscle during embryonic
myogenesis (Hasty et al., 1993; Kablar et al., 1998; Kassar-Duchossoy et al., 2004; Nabeshima
et al., 1993; Rudnicki et al., 1993). Although myogenin activates many genes required for
skeletal muscle development, it is not required for the activation of all skeletal muscle genes
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(Venuti et al., 1995). Furthermore, other MRF family members do not compensate for
myogenin’s loss (Rawls et al., 1995). These results suggest that myogenin efficiently activates
target genes required for differentiation, and these target genes are not efficiently activated by
compensatory mechanisms of other MRF family members.
To simplify the analysis of myogenin-dependent gene activation, the function of
myogenin is often compared with another MRF with broad functions throughout myogenesis,
MyoD. Recently, embryonic myogenin target genes were discovered using gene expression
profiling. Data analysis revealed that many of the differentially expressed genes were Z-line
structural components (Figure 36). The Z-line functions an anchor for contractile proteins.
ChIP analysis of selected genes showed preferential binding of myogenin rather than MyoD at
many of the transcriptional control regions upstream of these target genes (Davie et al., 2007)
(Figure 37).
Other investigators have published results that help elucidate the roles of myogenin and
MyoD during skeletal muscle development. These studies show MyoD may bind the TCRs of
many muscle-expressed genes at relatively earlier times than myogenin (Cao et al., 2006;
Ohkawa et al., 2006). MyoD contains an alpha-helix domain, not functionally conserved in
myogenin, which allows it to interact with cofactors such as the Pbx/Meis complex to mediate
the early stages of chromatin remodeling (Berkes et al., 2004). Pbx/Meis is constitutively bound
to many promoters of muscle specific genes and this may help recruit MyoD to nearby E-box
sites to promote the activation of these genes. This activity is thought to loosen the chromatin
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Figure 36 – Differentially expressed genes in embryonic muscle lacking myogenin.
RT-qPCR validation of selected differentially expressed genes in Myog-null E15.5
tongue muscle. These genes are generally involved in muscle contraction, structural
components, and found within the sarcomeric Z-disk of the myofiber. Blue bars indicate
wild-type control values; red bars indicate Myog-null values. Error bars represent one
standard deviation. Figure borrowed from (Davie et al., 2007).
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Figure 37 – Embryonic Myog-dependent target genes
ChIP analysis revealed that many differentially expressed genes in Myog-null embryonic
tongue muscle were also preferentially bound by Myog within their TCRs. Data is
presented as fold enrichment of the immunoprecipitation (IP) over mock IP. Red boxes
indicate gene TCRs where myogenin association is highly enriched. Blue bars indicate
wild-type control values; red bars indicate Myog-null values. Error bars represent one
standard deviation. Figure borrowed from (Davie et al., 2007).
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structure at some muscle-expressed genes later in development where myogenin can
subsequently bind the TCRs for efficient gene activation. While this is a promising result and
contributes to the mechanistic differences between myogenin and MyoD, it does not explain
why MyoD cannot compensate in myogenin germline-knockout mice. It also does not explain
why MyoD germline-knockout mice are apparently normal if myogenin would not have
complete access to its target genes.
Blais et al. analyzed the genome-wide binding of myogenin, MyoD, and Mef2 using
ChIP-chip technology (Blais et al., 2005). The authors discovered many distinct and overlapping
target-genes of myogenin and MyoD (Figure 38). An enriched list of myogenin-specific target
genes will contribute to the future understanding of why MyoD is not associated with the TCRs
of myogenin-specific genes.
The embryonic lethality observed in myogenin knockout mice precludes postnatal and
adult studies of skeletal muscle lacking this transcription factor. To circumvent this, a
conditional knockout was created where exon I of Myog, which contains the bHLH domain, was
flanked with loxP sites and deleted upon activation of the Cre-ER transgene via tamoxifen
injection (Hayashi and McMahon, 2002; Knapp et al., 2006) (Figure 2). When Myog was
deleted between E16.5 and birth, Myog-deleted mice died at birth due to asphyxiation. While it
was previously believed that most skeletal muscle has developed by E15.5 (Venuti et al., 1995),
closer inspection of Myog conditional knockout mice revealed that myogenin was required for
proper skeletal muscle formation until birth (Meadows et al., 2008).
To summarize, myogenin is a transcription factor that cannot be compensated for by the
other MRFs, and cannot activate all muscle-expressed genes. A detailed understanding of how
myogenin achieves this specificity to regulate skeletal muscle development is essential.
Identifying mechanisms involved in conferring myogenin target-gene specificity will allow for a

110

Figure 38 – A global comparison of genes bound by Myog and MyoD reveals many
distinct and overlapping target genes. ChIP on chip and RT-qPCR analyses reveal Myogdependent and MyoD-dependent target genes. Borrowed from (Blais et al., 2005).
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broader understanding of target gene regulation by transcription factor families. To help
facilitate this goal, a Tet-On-Myog cell culture system was engineered and employed.
The ability to conditionally express myogenin in Myog-deleted adult muscle stem cells
allowed for the analysis of myogenin-dependent target gene specificity. Tet-On-Myog
adult muscle stem cells were analyzed throughout the process of differentiation to
identify the TCRs where myogenin is binding and activating target gene transcription.
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Hypothesis

Mechanisms exist that allow myogenin, but not the three other MRFs, to bind more
efficiently to distinct E-box motifs present within the transcriptional control regions of many
genes expressed in skeletal muscle. These mechanisms are involved in conferring target gene
dependence on myogenin (Figure 39).

Specific Aims

1.) Engineer a cell culture system where myogenin is conditionally expressed to study
the process of myogenin-dependent gene regulation. Myog-deleted adult muscle stem
cells will be used for the stable viral integration of a Tet-On-Myog-GFP construct.
These cells will be characterized for myogenin expression, GFP expression, and a
doxycycline-dose dependent response of Myog induction.

2.) Identify a set of muscle-expressed genes that is strictly dependent on myogenin for
normal expression. Differentially expressed genes identified in previous studies serve
as potential Myog-dependent genes (Davie et al., 2007; Meadows et al., 2008) (Figures
36, 40). Genes from these studies will be used to determine whether they are strictly
dependent on myogenin in the context of adult muscle stem cells.

3.) Identify the regulatory elements and cofactors that confer target gene dependence
on myogenin for normal expression. ChIP analysis will be employed, along with
sequence analysis of myogenin-dependent gene TCRs, to identify potential mechanisms
that confer myogenin dependence in adult muscle stem cells.
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Figure 39 – Hypothesized model of myogenin target gene dependence.
At the TCR of myogenin-dependent genes, the following sequence of events would be
required for myogenin-dependent gene activation: 1.) Once canonical E-box motifs are
exposed, Myog will bind to E-box motifs and associate with unknown cofactor(s). The
cofactor(s) will help stabilize myogenin-promoter binding. 2.) Myogenin and the
unidentified cofactor(s) will cooperate to initiate gene transcription. The cofactor may
have a consensus-binding motif. MyoD will not interact with the cofactor(s) in the
context of a myogenin-dependent TCR, and will not efficiently initiate gene transcription.
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Figure 40 – Differentially expressed genes in muscle stem cells lacking myogenin.
RT-qPCR validation of selected differentially expressed genes in Myog-deleted muscle
stem cells. These genes are generally involved in cell fusion, adhesion, and signaling.
Blue bars indicate wild-type control values; red bars indicate Myog-null values. Error
bars represent one standard deviation. Figure borrowed from (Meadows et al., 2008).
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Chapter 5 - Results

Section 5.1 - Inducible myogenin expression in Tet-On-Myog-GFP adult muscle stem cells

Myog-deleted adult muscle stem cells [and embryonic myoblasts] were used to
genetically engineer a cell culture-based system where Myog is conditionally activated with a
Tet-On approach and easily visualized with a GFP reporter gene (Figure 41). The Clontech
pRetroX-Advanced System was used to facilitate this experiment (Figure 42). Initial screening,
selection, and characterization of the cells involved multiple methods. Clonal selections were
based on a 500 ng/ml concentration of doxycycline to efficiently identify clones with a low
basal expression of the Tet-On-Myog-GFP and a strong expression upon induction. Our
selected primary clones exhibited a combination of strong cytoplasmic GFP expression in the
+Dox state and extremely weak GFP expression in the –Dox state (Figure 43A). These clones
also exhibited strong nuclear expression of myogenin in the +Dox state and weak myogenin
expression in the –Dox state. RT-qPCR analysis revealed that the basal expression of Myog in
proliferating, non-Dox-induced Tet-On-Myog-GFP cells was only 15% of normal expression
found in wild-type control cells (Figure 43B). When these cells were treated with 500 ng/ml of
doxycycline, a strong ten-fold increase in Myog was observed relative to wild-type control cells
(Figure 43B). Myog-deleted adult muscle stem cells (negative control cells) expressed
myogenin at 5% of normal levels. These results demonstrate that we have successfully created
adult muscle stem cells [and embryonic myoblasts] where myogenin can be conditionally
activated, or completely removed, dependent on the presence of doxycycline.

Section 5.2 - Myogenin expression is doxycyline dose-dependent
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Figure 41 – Tet-On inducible myogenin system
Myog-deleted adult muscle stem cells express both a Myog-IRES-GFP driven by a Tetracycline
Response Element (TRE) and a reverse Tetracycline-controlled Transactivator (rtTA) protein
(A). Upon addition of doxycycline, the doxycycline will dock with the rtTA protein, allowing
the rtTA to bind with the TRE and to activate Myog-Ires-GFP gene expression (B). The
activation of Myog-Ires-GFP will lead to a cytoplasmic expression of GFP concomitant with a
nuclear expression of myogenin. Myogenin will proceed to activate myogenin-dependent target
gene expression.
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Figure 42 – Clontech’s pRetroX-Advanced System
The pRetroX-Tet-On-Advanced vector is designed to express the reverse Tetracyclinecontrolled Transactivator protein (rtTA) (A). The pRetroX-Tight-Pur vector is designed
to express a gene of interest (i.e. Myog-Ires-GFP) (A). The addition of doxycycline to
cells stably expressing both of these genes will allow the rtTA protein to bind the
Tetracycline Response Element (TRE) and activate gene expression (B). After each of
these vectors is transfected into packaging cells, virus may be harvested from the
supernatant. Serial infection and selection for Tet-On-Adv and then Myog-Ires-GFP
results in a double-stable Tet-On Advanced cell line (C). In the absence of doxycycline,
the Myog-deleted adult muscle stem cells will not express Myog, while the presence of
doxycycline will conditionally activate Myog expression. (www.Clontech.com)

122

123

Figure 43 – Inducible myogenin expression in adult muscle stem cells.
Myog-deleted adult muscle stem cells [and Myog-null embryonic myoblasts] were stably
integrated with the Tet-On Myog-Ires-GFP system. Cells exhibited very weak GFP
expression in the absence of doxycycline and strong cytoplasmic GFP expression after
the addition of 500 ng/mL doxycycline (A). Antibody staining for both myogenin and
GFP revealed nuclear localization of myogenin and cytoplasmic localization of GFP after
the addition of 500 ng/mL doxycycline (B, pictures). RT-qPCR revealed that doublestable Myog-deleted satellite cells, in the absence of doxycycline, express 15% of the
Myog levels found in wild-type satellite cells. After addition of 500 ng/mL doxycycline,
Myog expression is upregulated 10-fold. Myog-deleted satellite cell controls expressed
only 5% of wild-type Myog (B, graphs). Blue text and bars represents data from satellite
cells, orange text and bars represent data from embryonic myoblasts.
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In order to study Myog-dependent gene activation, we determined the proper dosage of
doxycycline to simulate physiological levels of Myog during cell differentiation. Tet-On-Myogdeleted cells demonstrated a dose-dependent response to the addition of varying concentrations
of doxycycline (Figure 44). After 48-hours of differentiation, -Dox cells showed a 27%
expression of Myog relative to wild-type control cells. The addition of 50 ng/mL of
doxycycline stimulated the expression of Myog at levels near 80% of control cells. Notably, for
every additional 50 ng/mL added beyond 50 ng/mL, an approximate two-fold increase in Myog
expression was observed. The addition of 100 ng/mL doxycycline stimulated myogenin to 2.3fold higher than control cells, 150 ng/mL yielded 4.7-fold Myog, 200 ng/mL yielded 9.3-fold
Myog, and 250 ng/mL yielded 16.6-fold Myog. These results demonstrate that Tet-On-MyogGFP cells can be manipulated to express a wide range of Myog expression levels in a dosedependent manner, and that wild-type levels of Myog may be obtained by treating the cells with
approximately 70 ng/mL doxycycline.

Section 5.3 - Adult myogenin-target gene activation in myogenin-induced adult muscle stem
cells

To identify a set of genes that exhibit a dependence on myogenin for expression,
previously identified differentially expressed genes in Myog-deleted adult muscle stem cells
were selected as candidate target genes. We also included previously identified and confirmed
embryonic myogenin-dependent target genes. Despite multiple RT-qPCR attempts to determine
the dependence of the selected genes on myogenin for normal expression, we were unsuccessful
at obtaining unambiguous data (Figures 45, 46). These data indicate that further optimization of
the Tet-On-Myog-GFP expression system is required in order to take full advantage of its
applicability.
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Figure 44 – Myog Expression is doxycycline dose-dependent
Double-stable Myog-deleted adult muscle stem cells were treated with a range of doxycycline
concentrations (50 ng/mL, 100 ng/mL, 150 ng/mL, 200 ng/mL, 250 ng/mL) and Myog
expression measured with RT-qPCR. For every additional 50 ng/mL increase in doxycycline,
the associated Myog expression increases approximately 2-fold. Approximately 70 ng/mL of
doxycycline appears to simulate wild-type expression levels of Myog. Error bars represent one
standard deviation.
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Figure 45 – Example experiment #1
RT-qPCR of selected genes expressed in double-stable Myog-deleted muscle stem cells
after the addition of 500 ng/mL doxycycline. Myog expression is increased 140-fold,
while MyoD, Myf5, and Mrf4 expression is unchanged. Selected potential adult target
genes of myogenin show a 2-fold or greater upregulation while selected and confirmed
embryonic target genes of myogenin remain unchanged in double-stable Myog-deleted
adult muscle stem cells. Blue bars represent baseline gene expression in the absence of
doxycycline, green bars represent result gene expression after the addition of
doxycycline. Error bars not shown due to irreproducibility.
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Figure 46 – Example experiment #2
RT-qPCR of selected genes expressed in double-stable Myog-deleted muscle stem cells
after the addition of 70 ng/mL doxycycline. Myog expression is increased 7-fold, while
MyoD, Myf5, and Mrf4 expression is unchanged. Selected potential adult target genes of
myogenin show aberrant gene expression changes while selected and confirmed
embryonic target genes of myogenin remain unchanged in double-stable Myog-deleted
muscle stem cells. Blue bars represent baseline gene expression in the absence of
doxycycline, green bars represent result gene expression after the addition of
doxycycline. Average of 3 independent experiments. Error bars represent one standard
deviation.
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Chapter 6 - Discussion

The mechanisms conferring target gene specificity upon individual members of
transcription factor families are poorly understood. An excellent example of this specificity is
found when comparing gene expression profiles between embryonic and adult muscle lacking
myogenin. Myogenin regulates the expression of contractile and structural components of
skeletal muscle in embryonic myogenesis, while it regulates a distinctly different set of target
genes in adult life. During adult life, myogenin appears to regulate the expression of genes
involved in signal transduction and metabolism. Furthermore, microarray analysis of adult
muscle stem cells lacking myogenin demonstrates that myogenin regulates genes involved in
cell adhesion, cell fusion, and cell signaling. Using a cell culture-based system where myogenin
may be conditionally expressed, we can gain insight into how muscle-expressed genes become
dependent on myogenin and why these genes lose their dependence on myogenin at different
times during life.
High levels of Myog expression may prevent or mitigate its selectivity because high
levels of myogenin may bind promiscuously to MRF E-box consensus sites. Using previously
isolated adult muscle stem cells that have been deleted of Myog in cell culture, we developed a
system that allowed us to tightly control the expression of myogenin. We successfully obtained
multiple cell lines that exhibited very low basal expression of Myog transcripts, myogenin
protein expression, and GFP reporter gene expression in the absence of doxycycline. Upon
addition of doxycycline, the selected cell lines exhibited efficient and robust up-regulation of
Myog transcripts, myogenin protein expression, and GFP reporter gene expression.
Furthermore, myogenin protein expression was successfully detected in the nucleus while GFP
expression was detected in the cytoplasm. Myog transcript expression was also dose-dependent
on doxycycline.
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After 48-hours of serum withdrawal, Tet-On-Myog-GFP cells efficiently expressed wildtype levels of Myog transcripts at low doses of doxycycline, demonstrating the ability to obtain
physiologically relevant levels of myogenin expression. Cells without doxycycline treatment
maintained less than heterozygous expression levels of Myog to maintain gene expression
patterns associated with myogenin’s absence. Certainly, Tet-On-Myog-GFP cells serve as an
excellent system to identify Myog-dependent genes.
Given that Myog-dependent target gene expression should be strictly dependent on the
presence of myogenin, RT-qPCR assays were used to determine whether genes were dependent
on myogenin. Despite the successful development of this cell line, technical problems impeded
progress on this project. After optimizing a number of issues, including FBS tetracyclineanalogs contaminating cell culture media, RT-qPCR conditions, and primer design, we were still
unsuccessful at detecting Myog-dependent target genes. Regardless of whether doxycycline was
added to the cells, gene expression was not consistently dependent on myogenin. Potential
reasons and solutions to this problem include:

1.) The clones expressing Tet-On-Myog-GFP were selected using excessive amounts of
doxycycline. As excessive amounts of doxycycline induce excessive Myog expression,
clones may not have been selected under ideal conditions. It is possible that clonal
selection using physiologically relevant levels of Myog may allow for the selection of
cells that efficiently express myogenin-dependent genes.
2.) The Myog-deleted muscle stem cells have started to senesce. The cells may be
particularly prone to high passage number, which could negatively influence myogenindependent target gene expression. This problem will be particularly difficult to
overcome and may require a complete reengineering of the cell line.
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3.) The dependence of predicted myogenin-dependent target genes is negatively influenced
by the vast number of manipulations performed during the creation of the cell line. The
stable integration of two viral vectors and overall passage number of the cells may
confer a completely different set of Myog-dependent genes in the Tet-On-Myog-GFP
cells. Myogenin could regulate a somewhat different set of target genes in the context of
this manipulated primary cell line. Genome-wide expression profiling would be
necessary to reveal genes that are newly dependent on myogenin.

Nevertheless, once Myog-dependent genes are identified in the context of inducible
Myog cells, a variety of critical issues can be addressed. The ability to coordinate the activation
of myogenin expression in millions of cells in concert provides an invaluable system for
studying Myog-dependent gene activation. TCRs responsible for conferring myogenin
dependence can be identified using rVista analysis (Figure 47) and then used for ChIP assays.
Myogenin-bound promoter elements can then be identified, and the expression of the associated
genes at specific time-points during myoblast differentiation can be determined. The overall
responsiveness of myogenin-dependent target genes towards myogenin can also be determined
using RT-qPCR.
In summary, Tet-On-Myog-GFP adult muscle stem cells provide a valuable resource for
monitoring and understanding the process of myogenin-dependent gene activation. The study of
these cells will broadly impact other studies where the aim is to distinguish the function of an
individual transcription factor from other members of its family.
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Figure 47 – Conserved E-box motifs are present within the TCRs of adult myogenin target
genes. Selected potential adult target genes of myogenin contain clusters of E-box and Mef2
binding motifs (indicated by green stars), as identified with rVista analysis.

136

137

       

Section 7.1 – DNA isolation and genotyping

The mouse line used for the project was homozygous for the Myogflox allele and
hemizygous for the CAGGCre-ER transgene (Hayashi and McMahon, 2002; Knapp et al.,
2006). These mice were of mixed background, containing both 129 & C57BL/6 strains.
Mouse-tail clippings were digested overnight at 65°C in tail lysis Buffer (10 mM Tris ph 8.0, 25
mM EDTA ph 8.0, 100 mM NaCl, 1% SDS) with 0.4g/l (final concentration) of proteinase
K. The DNA was phenol-chloroform extracted and diluted in ddH2O. PCR was performed
using the Qiagen Hotstart kit. PCR genotyping was performed on a ABI Gene AMP PCR
system model 9700 machine using the following conditions: denaturation 95°C 15 minutes, 35
cycles [denaturation 95°C for 15 seconds, annealing 58°C 30 seconds, extension 72°C 30
seconds], 5 minutes final extension. qPCR was performed using ABI SYBR mix on a ABI 7500
Fast Real Time PCR system using the following conditions: denaturation 95°C 10 minutes, 40
cycles [denaturation 95°C for 15 seconds, annealing/extension 58°C 30 seconds], 5 minutes
final extension. Mdx genotyping consisted of PCR-amplifying the Mdx Exon 23 locus, gelpurifying the PCR fragment, and sequencing the fragment using the Mdx Rev primer.
DNA Primers used for Genotyping and cloning:
CAGGCre-ER Fwd

5’-TCCAATTTACTGACCGTACACCAA-3’

CAGGCre-ER Rev

5’-CCTGATCCTGGCAATTTCGGCTA-3’

Myog Fwd

5’-GAGACATCCCCCTATTTCTACCA-3’

Myog Rev

5’-GCTCAGTCCGCTCATAGCC-3’

Myog-LoxP1 Fwd

5’-CCGGGTAGGAGTAATTGAAAGGA-3’
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Myog-LoxP1 Rev

5’-GCCGTCGGCTGTAATTTGAT-3’

MdxEx23 Fwd

5’-TGAAACTCATCAAATATGCGTGTTAG-3’

MdxEx23 Rev

5’-TGTTTCCCATCACATTTTCCAA-3’

Myog cDNA Fwd

5’-TTCCGACCTGATGGAGCTGTAT-3’

Myog cDNA Rev

5’-GGTAACCTCAGTTGGGCATGGTTTCGT-3’

Section 7.2 – Deleting Myog during adult life

After approximately 12 weeks of age, adult mice were given a single intraperitoneal
injection of tamoxifen (20 mg/ml in corn oil) at a dose of 0.25 mg/g body weight. Control mice
that did not express Cre were also treated with tamoxifen. Tamoxifen treatment efficiently
deleted Myog in skeletal muscle and allowed us to study the function of Myog during adult life.
In order to obtain efficient deletion of Myog, high doses of tamoxifen were critical. In the
process of treating the mice with tamoxifen and deleting their Myog locus, we observed a 15%
mortality rate. Our experiments have shown that lower doses and fewer treatments of
tamoxifen, which yield a lower mortality rate, do not efficiently delete Myog during adult life.

Section 7.3 – Voluntary cage wheel exercise

Plastic cage wheels were fitted with digital magnetic counters (Schwinn Bicycles)
activated by wheel rotation and anchored into cages (Coast Cages model no. 36412, Petsmart)
(Figure 26). The digital counters measure average running speed, maximum running speed,
total distance, and trip distance. Mice were subjected to voluntary exercise for a maximum of
six months. An arbitrary load of 1 kg was added to a wire that increased the rotational
resistance of the wheel axis. The load was measured using a common fish weight scale.
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Section 7.4 – Involuntary treadmill exercise

A six-lane Exer 3/6 Rodent Treadmill (Columbus Instruments) was used for involuntary
exercise experiments. Up to six mice were tested simultaneously. Acclimatization was
performed for three days prior to the experiment. Low-intensity acclimatization: zero degree
incline, 30 min @ 10 m/min. Low-intensity exercise: zero degree incline, 30 min @ 10 m/min,
20 m/min until exhaustion. High-intensity acclimatization: 10 degree incline, 10 min @ 10
m/min, additional 2 m/min every 2 min until 20 min total exercise time is reached. Highintensity exercise: 10 degree incline, 10 min @ 10 m/min, additional 2 m/min every 2 min until
exhaustion. Modified high-intensity acclimatization: none. Modified high-intensity exercise: 0
degree incline, 5 min @ 6 m/min, additional 1 m/min every 2 min until 10 m/min is reached,
additional 2 m/min every 2 min until exhaustion. Mice were run until exhaustion in each
experiment. Fatigue was operationally defined as the time at which the mouse is unable or
refusing to maintain its running speed for 10 seconds despite encouragement by mild electrical
stimulation. A stimulus grid located at the rear of the treadmill provided a physically harmless
0.2 mA stimulus. Electrical stimulation was discontinued when the mice reached fatigue.
Under high-intensity exercise conditions, mice were subjected to this treatment 5-7 times per
week for 1-2 months. Under low- and modified high-intensity exercise conditions, mice were
subjected to this treatment only once.

Section 7.5 – Blood metabolite assays

Blood metabolites were measured immediately before and after exercise. Blood glucose
and ketones were measured using a Precision Xtra Advanced Diabetes Management System
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(Abbott Diabetes Care Inc.). Blood lactate was measured with a Lactate Pro blood lactate test
meter (Arkray Inc.). Approximately 2 uL of blood was deposited onto the blood glucose, blood
ketone, and blood lactate test strips, and the test strips were then inserted into their respective
monitor for analysis.

Section 7.6 – Tissue harvest & histology

After mice were sacrificed, various muscle groups were harvested for RNA isolation and
histology. Muscles for RNA isolation were placed into an appropriate volume RNAlater
(Ambion) and stored at -80 C. Muscles for histology were snap frozen in LN2-cooled
isopentane and stored at -80 C. Ten-micrometer fresh-frozen sections were made using a Leica
Cryostat. Slides containing fresh-frozen sections were stored at -80 C.

Section 7.7 – Succinate dehydrogenase assay

Fresh frozen muscle sections were treated as follows: Nitroblue tetrazolium (NBT)
stock was prepared with 100mL 100mM phosphate buffer pH 7.6, 6.5 mg KCN, 185 mg EDTA,
100 mg NBT. Succinate stock was prepared as 500 mM sodium succinate. Incubation medium
consisted of 10% succinate stock in NBT stock with 0.7 mg phenazine methosulphate. The
incubation medium was prepared immediately prior to use and kept out of strong light. The
reaction was completed within 5 minutes. The sections were then rinsed in distilled water, fixed
in 4% PFA, dehydrated, cleared, and mounted. Modified from (Pette and Tyler, 1983). SDH
activity was found to colocalize with myoglobin expression (Abcam ab77232) (Supplemental
Figure 48).
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Figure 48 – Co-localized expression of myoglobin and succinate dehydrogenase activity.
Myoglobin protein, as shown by immunohistochemistry, is expressed in highly oxidative SDHpositive myofibers of the gastrocnemius. Serial sections are shown.
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Section 7.8 – Adenosine Triphosphate (ATP) staining protocol

The pH 4.3 ATP protocol was the most preferred and reliable method for distinguishing
Type-I and Type-II fibers. Type-I fibers are visibly dark while Type II fibers are visibly light
following this procedure. The following solutions are prepared prior to the staining procedure:
0.1 M sodium barbital, 0.18 M calcium chloride, 1% calcium chloride, barbital acetate solution
(1.47 g sodium barbital and 0.97 g sodium acetate into 50 mL ddH20), 1 N NaOH, 0.1 N NaOH,
1 N HCl, 0.1 N HCl, “4.3 ATP” pre-incubation solution (5.0 mL barbital acetate solution, 10
mL 0.1 N HCl, 4.0 mL ddH20, adjust pH with 1 N HCl), ATP incubating solution (60 mg ATP
powder, 6.0 mL 0.1 M sodium barbital, 21.0 mL ddH20, 3.0 mL 0.18 M calcium chloride,
adjust pH with 1N NaOH), 50% ethanol, 70% ethanol, 80% ethanol, 95% ethanol, 2%
ammonium sulfide (prepare immediately prior to use).
Staining procedure: Incubate fresh frozen sections in 4.3 solution for exactly 5 minutes
at room temperature. Rinse with ddH2O. Incubate with ATP solution for 25 minutes. Wash
sections with 3 changes of 1% calcium chloride for a total of 10 minutes. Wash sections with
2% cobalt chloride for 10 minutes. Wash with 3-5 changes of a 1:20 solution of 0.1 M sodium
barbital (in ddH2O); wash should turn a faint blue color. Wash with 5 exchanges of ddH2O.
Wash with 2% ammonium sulfide for 20-30 seconds. Rinse with 5 changes of tap water.
Dehydrate in ascending alcohols, clear in xylene, and mount only with Canada balsam. (Brooke
and Kaiser, 1970a; Brooke and Kaiser, 1970b) Borrowed from
http://neuromuscular.wustl.edu/pathol/histol/atp.htm

Section 7.9 – RNA isolation & RT-qPCR
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RNA was isolated from semi-confluent satellite cell lines and hind limb muscle
homogenates with the Invitrogen Trizol protocol. Tissue homogenization was performed with a
Wheaton 1mL Dounce tissue grinder. Muscle samples were homogenized in Trizol directly
from fresh or fresh-frozen muscle tissue. RNA was then used with the ABI RNA to cDNA kit
for reverse transcription. SYBR RT-qPCR was performed with ABI Power-SYBR master mix
and on the ABI 7500 Fast Real Time PCR system with version 2.0.1 software, and using the
following default conditions: denaturation 95°C 10 minutes, 40 cycles [denaturation 95°C 15
seconds, annealing/extension 60°C 30 seconds], 5 minutes final extension. Taqman RT-qPCR
assays were performed with ABI Taqman Master mix (FAM/ROX) and using default
parameters. Proper dynamic range was determined for Gapdh and Myog Taqman
primer/probes. All reactions were normalized to GAPDH expression. Unpaired 2-class t-tests
were performed using Microsoft Excel 2007. Samples were analyzed, at minimum, in
biological triplicate.
cDNA primer pairs used were:
Gapdh Fwd

5’-CCACCAACTGCTTAGCACC-3’

Gapdh Rev

5’-GCCAAATTCGTTGTCACACC-3’

Myog Fwd

5’-GAGACATCCCCCTATTTCTACCA-3’

Myog Rev

5’-GCTCAGTCCGCTCATAGCC-3’

ABI Taqman Primer/Probe Sets:
GAPDH Endogenous Control (FAM/MGB Probe)
Myog LoxP Custom Fwd: GGCCCGGGTAGGAGTAATTG
Myog LoxP Custom Rev: CCGTCGGCTGTAATTTGATTAGT
Myog LoxP Custom Probe: AAGGAGCAGATGAGACGG
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Myogenin, Assay ID Mm00446194_m1
Myosin, heavy polypeptide 7, Assay ID Mm00600555_m1
Myosin, heavy polypeptide 4, Assay ID Mm01332541_m1
Myosin, 2A, Assay ID Mm00454982_m1
UCP2, Assay ID Mm00627599_m1
UCP3, Assay ID Mm00494077_m1
Cox8b, Assay ID Mm00432648_m1
Glut4, Assay ID Mm00436615_m1
CD36, Assay ID Mm01135198_m1
Acc2, Assay ID Mm01204691_m1
ppar-a, Assay ID Mm00627559_m1
ppar-g, Assay ID Mm00440945_m1
Cpt1, Assay ID Mm00550438_m1
Rfx7, Assay ID Mm01146805_m1
Nfatc2, Assay ID Mm00477776_m1
RhoBTB1, Assay ID Mm01143659_m1
Rhpn2, Assay ID Mm00518451_m1
Htra1, Assay ID Mm00479887_m1
Gpx3, Assay ID Mm00492427_m1
Zscan21, Assay ID Mm00442147_m1
Pcx, Assay ID Mm00500992_m1
Bmp5, Assay ID Mm00432091_m1
Pfkfb3, Assay ID Mm00504650_m1
Mpa2l, Assay ID Mm00843395_m1
Dpyd, Assay ID Mm00468111_m1
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Bdh1, Assay ID Mm00558330_m1
AdamTS5, Assay ID Mm01344182_m1
CD24a, Assay ID Mm00782538_sH
Itga4, Assay ID Mm00439770_m1
Ptgis, Assay ID Mm00447271_m1
Sema3d, Assay ID Mm00712652_m1
Socs3, Assay ID Mm01249143_g1
Ampd1, Assay ID Mm01308676_m1
Casq2, Assay ID Mm00486742_m1
Fgf6, Assay ID Mm01183111_m1
Ldb3, Assay ID Mm00522021_m1
Lmod2, Assay ID Mm01165337_m1
Myf5, Assay ID Mm00435125_m1
Mrf4, Assay ID Mm00435126_m1
Myod1, Assay ID Mm0040387_m1

Section 7.10 – RNA quality control and gene chip hybridization

Using RNA isolated from the Myog wild-type control and Myog-deleted adult
gastrocnemius muscle, quality control was first carried out by the microarray core.
Approximately 1 g of each sample was submitted to insure the 28s and 18s ribosomal RNA
bands were of sufficient relative intensity and that the RNA concentration and amount was
sufficient. Once this was approved, each sample was submitted for hybridization. The
Affymetrix 430 2.0 microarray platform was used for this analysis as it covers approximately
40,000 transcripts within the mouse genome.
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Section 7.11 – Microarray data analysis

Genespring GX10 was used to analyze the raw microarray data. The 6 raw data sets
were loaded into the program and each data set was labeled as being either control or
experimental. Normalization was performed using the RMA algorithm. Unpaired two-class ttests were performed without error stabilization or p-value correction and p-value cutoffs were
set at p<0.05. Genespring GX10 and Microsoft Excel 2007 were used for statistical analysis.
From the filtered data set, all genes changing 1.4 fold were kept for further analysis.

Section 7.12 – Cell culture

Previously characterized adult muscle stem cells (Meadows et al., 2008) were
maintained in Gibco F-10 Media supplemented with Clontech Tet-free FBS and Invitrogen
Antibiotic-Antimycotic (ABAM). The cells were differentiated with DMEM supplemented
with 2% Horse Serum and ABAM. Cells were stored in LN2 prior to use.

Section 7.13 – Cloning and retroviral integration of Myog-Ires-GFP into adult muscle stem
cells

The RetroX Tet-On Advanced Inducible Expression System (Clontech) was used to
create doxycycline-inducible-myogenin adult muscle stem cells. Myog cDNA was PCRamplified with Myog cDNA primers (Section 7.1) from Myog full length cDNA (Open
Biosystems Acc:BC068019), gel-purified, and cloned into pCR 2.1 Topo (Invitrogen). A IRESGFP sequence was cut from a pIRES-hrGFP vector (Stratagene) with BstEII/XhoI and ligated
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into Topo-Myog, yielding Topo-Myog-GFP. Myog-GFP was then cut out (BamHI/XbaI) and
ligated into the MCS of pRetroX-Tight-Pur (dam- competent cells), yielding pRetroX-MyogGFP. As the Myogflox/flox adult muscle stem cells contain a neomycin cassette, originally used
for selection during gene targeting, the neomycin cassette contained in pRetroX-Tet-OnAdvanced was cut out (BstXI/RsrII) and replaced with a Blasticidin selection cassette. The
Blasticidin selection cassette came from (pBlast49-hIGF1a). The resulting vector was named
pRetroX-Advanced-Blast.
Packaging cells (EcoPack 2-293, Clontech) were next transfected with pRetroX-MyogGFP, pRetroX-Tight-Luc (control), and pRetroX-Advanced-Blast. Viral supernatants were
collected 48 hours after transfection. Muscle stem cells were infected with pRetroX-Adv-Blast
in the presence of Blasticidin and approximately 30 stably infected colonies were selected.
These colonies were next infected with pRetroX-Tight-Luc, and luciferase assays were
performed in the presence and absence of doxycycline (500 ng/mL; 3 days) to determine which
colonies exhibited the strongest luciferase induction. pRetroX-Adv-Blast satellite cells #5
exhibited strong luciferase induction, approximately 25-fold. The selected single stable muscle
stem cells were next infected with pRetroX-Myog-GFP in the presence of puromycin. Based
upon previous experiments with pRetroX-Myog-GFP to determine titer and colony forming unit
(CFU) characteristics, 100 uL of a 1000-fold dilution of virus was added to 3 mL of media to
keep copy numbers per cell to a minimum while yielding high infection efficiency.
Approximately 30 double stable infected colonies were selected for further analysis. Using
confocal microscopy to assay the induction of GFP expression in the presence and absence of
doxycycline (500 ng/mL; 3 days), colonies numbered 1, 6, 8, 12, 21, 23, and 25 exhibited the
least amount of background GFP expression and the strongest induction. RNA from these seven
colonies (induced and non-induced) was harvested for RT-qPCR for Myog expression, which
revealed colony #12 as showing the best induction of Myog and #23,25 the next best. 38 vials
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of colony 12, 10 vials (each) of colonies 23 & 25, and 1 vial each of the remaining colonies
were frozen in LN2. All infections were performed in the presence of 4 ug/mL of polybrene.

Section 7.14 – Doxycycline concentration curve

Double stable adult muscle stem cells (colony #12) were treated with 0, 50, 100, 150,
200, and 250 ng/mL of doxycycline under proliferative conditions. After 24 hours of
doxycycline treatment, the cells were differentiated for 48 hours and treated with doxycycline
for an additional 48 hours (72 hours total). Wild-type adult muscle stem cells were used as
controls. RNA was then harvested using the Trizol method and RT-qPCR performed to
determine the fold-induction of Myog associated with doxycycline concentration.

Section 7.15 – Immunofluorescence

Immunofluorescence was performed on adult muscle stem cells and embryonic myoblast
cell lines plated on 2 or 4 well chamber slides, antibody probed, and imaged by an Olympus
IX70 confocal microscope. Cells were first plated on 2 or 4 well chamber slides with a total cell
count of either 10x104 or 5x104 cells per well, respectively. No-primary antibody controls were
used for each cell line probed. The cells were given at least 24 hours to adhere to the slide (and
differentiate if necessary) before beginning. The media was first aspirated and the chambers
removed from each slide. The slides were rinsed in PBS and the cells were fixed with 4% paraformaldehyde (in PBS) for 30 minutes. The cells were then washed with PBS for 5 minutes 3times and then permeablized with PBST (0.5% Triton X-100 in PBS) for 10 minutes. Another 5
minutes 3-times PBS wash followed and the cells were then blocked in 2% BSA (in PBST) at
room temperature for 1 hour. The primary antibody was then added at a dilution of 1:200 in
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PBS (.5% BSA) for 1 hour. Primary antibodies used were against myogenin (sc-576) and GFP
(Vitality hrGFP monoclonal antibody 240241, Stratagene). The cells were again washed with
PBS for 5 minutes 3-times and the secondary antibody was then added at 1:400 (up to 1:200)
dilution in PBS for 1 hour. Secondary antibodies used were Cy3 anti-mouse (Jackson Immuno),
Cy5 anti-rabbit (Jackson Immuno), and Alexa488 anti-goat (Molecular Probes). After the
secondary antibody incubation, the cells were washed with PBS for 10 minutes 3-times and kept
out of direct light. Excess PBS was then dripped from the slides and 2 to 3 drops of AquaMount added before the glass coverslip was carefully placed over the cells. The slides were
stored in the dark at 4°C and imaged using a confocal microscope. Background intensity was
first checked using the no-antibody control samples before analyzing the antibody-stained cells
for signal.

Section 7.16 – Statistical analysis

All t-tests in this dissertation were two-tailed and unpaired, performed in Microsoft
Excel 2007 or 2008. The superior adaptation to exercise training was performed using a box
plot (BLiP) by Lei Feng (MD Anderson Biostatistics).
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